Aviv Reit 10-Q 31 Oct 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 15, 2014
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'AVIV	'
Entity Registrant Name	'AVIV REIT, INC.	'
Entity Central Index Key	'0001499686	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Non-accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	47,248,463
Aviv Healthcare Properties Limited Partnership	'	'
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Entity Registrant Name	'AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP	'
Entity Central Index Key	'0001519120	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Non-accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	11,416,426

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Income producing property	'	'
Land	$171,098	$138,150
Buildings and improvements	1,498,117	1,138,173
Assets under direct financing leases	11,262	11,175
Real Estate Investment Property, at Cost, Total	1,680,477	1,287,498
Less accumulated depreciation	-175,983	-147,302
Construction in progress and land held for development	34,421	23,292
Net real estate	1,538,915	1,163,488
Cash and cash equivalents	15,834	50,764
Straight-line rent receivable, net	44,000	40,580
Tenant receivables, net	2,011	1,647
Deferred finance costs, net	17,651	16,643
Loan receivables, net	43,272	41,686
Other assets	15,805	15,625
Total assets	1,677,488	1,330,433
Liabilities and equity	'	'
Secured loan	13,478	13,654
Unsecured notes payable	652,410	652,752
Line of credit	175,000	20,000
Accrued interest payable	10,903	15,284
Dividends and distributions payable	21,078	17,694
Accounts payable and accrued expenses	11,894	10,555
Tenant security and escrow deposits	24,066	21,586
Other liabilities	10,419	10,463
Total liabilities	919,248	761,988
Equity:	'	'
Common stock (par value $0.01; 47,216,963 and 37,593,910 shares issued and outstanding, as of September 30, 2014 and December 31, 2013, respectively)	472	376
Additional paid-in-capital	722,030	523,658
Accumulated deficit	-112,119	-89,742
Total stockholders' equity	610,383	434,292
Noncontrolling interests - operating partnership	147,857	134,153
Total equity	758,240	568,445
Total liabilities and equity	1,677,488	1,330,433
Aviv Healthcare Properties Limited Partnership	'	'
Income producing property	'	'
Land	171,098	138,150
Buildings and improvements	1,498,117	1,138,173
Assets under direct financing leases	11,262	11,175
Real Estate Investment Property, at Cost, Total	1,680,477	1,287,498
Less accumulated depreciation	-175,983	-147,302
Construction in progress and land held for development	34,421	23,292
Net real estate	1,538,915	1,163,488
Cash and cash equivalents	15,834	50,764
Straight-line rent receivable, net	44,000	40,580
Tenant receivables, net	2,011	1,647
Deferred finance costs, net	17,651	16,643
Loan receivables, net	43,272	41,686
Other assets	15,805	15,625
Total assets	1,677,488	1,330,433
Liabilities and equity	'	'
Secured loan	13,478	13,654
Unsecured notes payable	652,410	652,752
Line of credit	175,000	20,000
Accrued interest payable	10,903	15,284
Dividends and distributions payable	21,078	17,694
Accounts payable and accrued expenses	11,894	10,555
Tenant security and escrow deposits	24,066	21,586
Other liabilities	10,419	10,463
Total liabilities	919,248	761,988
Equity:	'	'
Partners' capital	758,240	568,445
Total liabilities and equity	$1,677,488	$1,330,433

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Mar. 25, 2013
Common stock, par value	$0.01	$0.01	'
Common stock, shares issued	47,216,963	37,593,910	'
Common stock, shares outstanding	47,216,963	37,593,910	21,700,000

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues	'	'	'	'
Rental income	$46,079	$31,693	$127,941	$99,206
Interest on loans and financing lease	1,101	1,131	3,263	3,272
Interest and other income	191	49	1,232	128
Total revenues	47,371	32,873	132,436	102,606
Expenses	'	'	'	'
Interest expense incurred	12,376	8,577	36,489	29,599
Amortization of deferred financing costs	988	810	2,944	2,516
Depreciation and amortization	11,522	8,302	31,470	24,399
General and administrative	5,297	3,867	16,960	21,150
Transaction costs	1,220	1,210	3,813	1,906
Loss on impairment	1,479	'	2,341	'
Reserve for uncollectible loans and other receivables	9	27	3,509	57
Loss (gain) on sale of assets, net	2,445	13	2,458	-26
Loss on extinguishment of debt	'	'	501	10,974
Total expenses	35,336	22,806	100,485	90,575
Net income	12,035	10,067	31,951	12,031
Net income allocable to noncontrolling interests - operating partnership	-2,344	-2,446	-6,662	-3,236
Net income allocable to common stockholders	9,691	7,621	25,289	8,795
Basic:	'	'	'	'
Net income allocable to common stockholders	$0.21	$0.20	$0.58	$0.27
Diluted:	'	'	'	'
Net income allocable to common stockholders	$0.20	$0.20	$0.56	$0.26
Weighted average common shares/units outstanding:	'	'	'	'
Basic	47,213,612	37,271,714	43,576,705	32,408,843
Diluted	60,967,867	50,838,529	57,127,784	42,101,077
Dividends declared per common share	$0.36	$0.36	$1.08	$0.74
Aviv Healthcare Properties Limited Partnership	'	'	'	'
Revenues	'	'	'	'
Rental income	46,079	31,693	127,941	99,206
Interest on loans and financing lease	1,101	1,131	3,263	3,272
Interest and other income	191	49	1,232	128
Total revenues	47,371	32,873	132,436	102,606
Expenses	'	'	'	'
Interest expense incurred	12,376	8,577	36,489	29,599
Amortization of deferred financing costs	988	810	2,944	2,516
Depreciation and amortization	11,522	8,302	31,470	24,399
General and administrative	5,297	3,867	16,960	21,150
Transaction costs	1,220	1,210	3,813	1,906
Loss on impairment	1,479	'	2,341	'
Reserve for uncollectible loans and other receivables	9	27	3,509	57
Loss (gain) on sale of assets, net	2,445	13	2,458	-26
Loss on extinguishment of debt	'	'	501	10,974
Total expenses	35,336	22,806	100,485	90,575
Net income	12,035	10,067	31,951	12,031
Net income allocable to noncontrolling interests - operating partnership	'	'	'	-1,008
Net income allocable to common stockholders	$12,035	$10,067	$31,951	$11,023
Basic:	'	'	'	'
Net income allocable to common stockholders	$0.21	$0.20	$0.58	$0.27
Diluted:	'	'	'	'
Net income allocable to common stockholders	$0.20	$0.20	$0.56	$0.26
Weighted average common shares/units outstanding:	'	'	'	'
Basic	58,633,389	49,210,134	55,055,248	40,630,173
Diluted	60,967,867	50,838,529	57,127,784	42,101,077
Dividends declared per common share	$0.36	$0.36	$1.08	$0.74

Consolidated_Statement_of_Chan

Consolidated Statement of Changes in Equity (USD $)	Total	Aviv Healthcare Properties Limited Partnership	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Parent	Noncontrolling Interest - Operating Partnership	Partners' Capital
In Thousands, except Share data								Aviv Healthcare Properties Limited Partnership
Balance at Dec. 31, 2013	$568,445	'	$376	$523,658	($89,742)	$434,292	$134,153	$568,445
Balance (in shares) at Dec. 31, 2013	37,593,910	'	37,593,910	'	'	'	'	'
Non-cash stock-based compensation	3,602	'	'	3,602	'	3,602	'	3,602
Shares issued for settlement of management vested stock and exercised stock options, net	3,053	'	2	3,051	'	3,053	'	3,053
Shares issued for settlement of management vested stock and exercised stock options, net (in shares)	'	'	223,197	'	'	'	'	'
Distributions to partners	-12,374	'	-47,666	'	'	'	-12,374	-60,040
Capital contributions	60	'	'	'	'	'	60	60
Proceeds from issuance of common stock (in shares)	'	'	9,200,000	'	'	'	'	'
Proceeds from issuance of common stock	221,720	'	92	221,628	'	221,720	'	221,720
Cost of raising capital	-10,551	'	'	-10,551	'	-10,551	'	-10,551
Dividends to stockholders	-47,666	'	'	'	-47,666	-47,666	'	'
Conversion of OP Units	'	'	2	2,341	'	2,343	-2,343	'
Conversion of OP Units (in shares)	'	'	199,856	'	'	'	'	'
Adjustment of noncontrolling interests-operating partnership ownership	'	'	'	-21,699	'	-21,699	21,699	'
Net income	31,951	31,951	'	'	25,289	25,289	6,662	31,951
Balance at Sep. 30, 2014	758,240	'	472	722,030	-112,119	610,383	147,857	758,240
Balance (in shares) at Sep. 30, 2014	47,216,963	'	47,216,963	'	'	'	'	'
Balance at Jun. 27, 2014	'	'	'	'	'	'	'	'
Distributions to partners	'	'	-17,009	'	'	'	'	'
Net income	12,035	12,035	'	'	'	'	'	'
Balance at Sep. 30, 2014	$758,240	'	$472	'	'	'	'	'
Balance (in shares) at Sep. 30, 2014	47,216,963	'	47,216,963	'	'	'	'	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Operating activities	'	'
Net income	$31,951	$12,031
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	31,470	24,399
Amortization of deferred financing costs	2,944	2,516
Accretion of debt premium	-401	-377
Straight-line rental income, net	-3,420	-2,998
Rental income from intangible amortization, net	-539	-1,097
Non-cash stock-based compensation	3,602	10,930
Loss (gain) on sale of assets, net	2,458	-26
Non-cash loss on extinguishment of debt	494	5,161
Loss on impairment	2,341	'
Reserve for uncollectible loan and other receivables	3,509	57
Changes in assets and liabilities:	'	'
Tenant receivables	-662	-3,785
Other assets	-545	1,058
Accounts payable and accrued expenses	-6,395	-9,468
Tenant security deposits and other liabilities	3,281	-2,006
Net cash provided by operating activities	70,088	36,395
Investing activities	'	'
Purchase of real estate	-368,870	-38,076
Proceeds from sales of real estate, net	1,337	4,842
Capital improvements	-10,293	-9,909
Development projects	-30,316	-14,380
Loan receivables received from others	7,613	3,222
Loan receivables funded to others	-12,410	-2,707
Net cash used in investing activities	-412,939	-57,008
Financing activities	'	'
Borrowings of debt	283,000	160,000
Repayment of debt	-128,117	-353,203
Payment of financing costs	-4,588	-5,290
Capital contributions	60	425
Proceeds from issuance of common stock	221,720	303,600
Cost of raising capital	-10,551	-25,380
Shares issued for settlement of vested stock and exercised stock options, net	3,053	'
Cash distributions to partners	-12,449	-16,276
Cash dividends to stockholders	-44,207	-48,907
Net cash provided by (used in) financing activities	307,921	14,969
Net decrease in cash and cash equivalents	-34,930	-5,644
Cash and cash equivalents:	'	'
Beginning of period	50,764	17,876
End of period	15,834	12,232
Supplemental cash flow information	'	'
Cash paid for interest	41,728	39,645
Supplemental disclosure of noncash activity	'	'
Accrued dividends payable to stockholders	17,009	'
Accrued distributions payable to partners	4,069	'
Write-off of straight-line rent receivable	1,380	2,887
Write-off of deferred financing costs, net	501	5,161
Aviv Healthcare Properties Limited Partnership	'	'
Operating activities	'	'
Net income	31,951	12,031
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	31,470	24,399
Amortization of deferred financing costs	2,944	2,516
Accretion of debt premium	-401	-377
Straight-line rental income, net	-3,420	-2,998
Rental income from intangible amortization, net	-539	-1,097
Non-cash stock-based compensation	3,602	10,930
Loss (gain) on sale of assets, net	2,458	-26
Non-cash loss on extinguishment of debt	494	5,161
Loss on impairment	2,341	'
Reserve for uncollectible loan and other receivables	3,509	57
Changes in assets and liabilities:	'	'
Tenant receivables	-662	-3,785
Other assets	-545	1,058
Accounts payable and accrued expenses	-6,395	-9,468
Tenant security deposits and other liabilities	3,281	-2,006
Net cash provided by operating activities	70,088	36,395
Investing activities	'	'
Purchase of real estate	-368,870	-38,076
Proceeds from sales of real estate, net	1,337	4,842
Capital improvements	-10,293	-9,909
Development projects	-30,316	-14,380
Loan receivables received from others	7,613	3,222
Loan receivables funded to others	-12,410	-2,707
Net cash used in investing activities	-412,939	-57,008
Financing activities	'	'
Borrowings of debt	283,000	160,000
Repayment of debt	-128,117	-353,203
Payment of financing costs	-4,588	-5,290
Capital contributions	60	425
Proceeds from issuance of common stock	221,720	303,600
Cost of raising capital	-10,551	-25,380
Shares issued for settlement of vested stock and exercised stock options, net	3,053	'
Cash distributions to partners	-56,656	-65,183
Net cash provided by (used in) financing activities	307,921	14,969
Net decrease in cash and cash equivalents	-34,930	-5,644
Cash and cash equivalents:	'	'
Beginning of period	50,764	17,876
End of period	15,834	12,232
Supplemental cash flow information	'	'
Cash paid for interest	41,728	39,645
Supplemental disclosure of noncash activity	'	'
Accrued distributions payable to partners	21,078	'
Write-off of straight-line rent receivable	1,380	2,887
Write-off of deferred financing costs, net	$501	$5,161

Description_of_Operations_and_

Description of Operations and Formation	9 Months Ended
	Sep. 30, 2014
Description of Operations and Formation	'
	1. Description of Operations and Formation
	Aviv REIT, Inc., a Maryland corporation (AVIV or the REIT), is the sole general partner of Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership, and its subsidiaries (the Partnership). The Partnership is a majority owned subsidiary that indirectly owns all of the real estate properties. In these footnotes, the Company refers generically to AVIV, the Partnership, and their subsidiaries. The Partnership was formed in 2010 and directly or indirectly owned or leased 313 properties, principally skilled nursing facilities (SNFs), across the United States at September 30, 2014. The Company is a fully integrated self-administered real estate investment trust that owns, acquires, develops and generates the majority of its revenues by entering into long-term triple-net leases with qualified local, regional, and national operators. In addition to the base rent, leases provide for operators to pay the Company an ongoing escrow for real estate taxes. Furthermore, all operating and maintenance costs of the buildings are the responsibility of the operators. Substantially all depreciation expense reflected in the consolidated statements of operations relates to the ownership of real estate properties.
	The Partnership is the general partner of Aviv Healthcare Properties Operating Partnership I, L.P. (the Operating Partnership), a Delaware limited partnership, the sole stockholder of Aviv Healthcare Capital Corporation, a Delaware corporation, and the sole member of Aviv Asset Management, L.L.C. (AAM), a Delaware limited liability company. The Operating Partnership has five wholly owned subsidiaries: Aviv Financing I, L.L.C. (Aviv Financing I), a Delaware limited liability company; Aviv Financing II, L.L.C. (Aviv Financing II), a Delaware limited liability company; Aviv Financing III, L.L.C. (Aviv Financing III), a Delaware limited liability company; Aviv Financing IV, L.L.C. (Aviv Financing IV), a Delaware limited liability company; and Aviv Financing V, L.L.C. (Aviv Financing V), a Delaware limited liability company.
	All of the business, assets and operations of the Company are held by the Partnership and its subsidiaries. The REIT’s equity interest in the Partnership is linked to future investments in the REIT, such that future equity issuances by the REIT (pursuant to the Partnership’s partnership agreement) will result in a corresponding increase in the REIT’s equity interest in the Partnership. The REIT is authorized to issue 300 million shares of common stock (par value $0.01) and 25 million shares of preferred stock (par value $0.01). The REIT was funded in September 2010 with 13.2 million shares and approximately $235 million from one of the REIT’s stockholders, and approximately 8.5 million additional shares of common stock were issued by the REIT in connection with $159 million of equity contributions by one of the REIT’s stockholders. The Partnership’s capital consists of partnership units, referred to as OP units, which are owned by AVIV and other investors.
	On March 7, 2013, the Board of Directors and stockholders of the REIT approved an increase in the number of authorized shares of common stock to 300,000,000 shares of common stock and a 60.37-for-one split of issued and outstanding common stock. The increase in the authorized shares and the stock split became effective on March 8, 2013 when the REIT’s charter was amended for such increase in the number of authorized REIT shares and the stock split. The common share and per common share amounts in these consolidated financial statements and notes to consolidated financial statements have been retrospectively restated to reflect the 60.37-for-one split.
	On March 26, 2013, the REIT completed an initial public offering (IPO) of its common stock pursuant to a registration statement filed with the SEC, which became effective on March 20, 2013. The Company received net proceeds, after underwriting discounts and commissions, of $282.3 million, exclusive of other costs of raising capital in consideration for the issuance and sale of approximately 15.2 million shares of common stock (which included approximately 2.0 million shares sold to the underwriters upon exercise of their option to purchase additional shares to cover over-allotments) at a price to the public of $20.00 per share. In connection with the IPO, the Partnership’s existing Class A, B, C, D and F Units were converted into a single class of OP units.
	Immediately prior to the completion of the IPO, there were outstanding approximately 21.7 million shares of common stock of the REIT, limited partnership units of the Partnership which were converted into approximately 11.9 million OP units in connection with the IPO, and 125 shares of preferred stock of the REIT. On April 15, 2013, the 125 shares of preferred stock outstanding were redeemed. At September 30, 2014, there were approximately 47.2 million shares of common stock outstanding and 11.4 million OP units outstanding, which OP units are redeemable for cash or, at the REIT’s option, for shares of common stock of the REIT. The operating results of the Partnership are allocated based upon the REIT’s and the limited partners’ respective economic interests therein. The REIT’s ownership of the Partnership was 80.5% and 76.4% as of September 30, 2014 and December 31, 2013, respectively. The REIT’s weighted average economic ownership of the Partnership for the three and nine months ended September 30, 2014 and 2013 were 80.52%, 79.15%, 75.7%, and 73.1%, respectively.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Summary of Significant Accounting Policies	'
	2. Summary of Significant Accounting Policies
	Basis of Presentation
	This report combines the Quarterly Reports on Form 10-Q for the quarter ended September 30, 2014 of AVIV and the Partnership. AVIV is a real estate investment trust (REIT) and the sole general partner of the Partnership. The Partnership’s capital consists of OP units. As the sole general partner of the Partnership, AVIV has exclusive control of the Partnership’s day-to-day management.
	The Company believes combining the Quarterly Reports on Form 10-Q of AVIV and the Partnership into this single report provides the following benefits:
		•		enhances investors’ understanding of AVIV and the Partnership by enabling investors to view the business as a whole in the same manner as management views and operates the business;
		•		eliminates duplicative disclosure and provides a more streamlined and readable presentation because a substantial portion of the disclosure in this report applies to both AVIV and the Partnership; and
		•		creates time and cost efficiencies through the preparation of one combined report instead of two separate reports.
	Management operates AVIV and the Partnership as one business. The management of AVIV consists of the same individuals as the management of the Partnership.
	The Company believes it is important for investors to understand the few differences between AVIV and the Partnership in the context of how AVIV and the Partnership operate as a consolidated company. AVIV is a REIT, whose only material asset is its ownership of OP units of the Partnership. As a result, AVIV does not conduct business itself, other than acting as the sole general partner of the Partnership, issuing public equity from time to time and guaranteeing unsecured debt of the Partnership. AVIV has not issued any indebtedness, but has guaranteed all of the unsecured debt of the Partnership. The Partnership indirectly holds all the real estate assets of the Company. Except for net proceeds from public equity issuances by AVIV, which are contributed to the Partnership in exchange for OP units, the Partnership generates all remaining capital required by the Company’s business. The sources of the remaining capital include the operations of the Partnership’s direct and indirect subsidiaries, its direct or indirect incurrence of indebtedness, and the issuance of OP units.
	As general partner with control of the Partnership, AVIV consolidates the Partnership for financial reporting purposes. The presentation of stockholders’ equity and partners’ capital are the main areas of difference between the consolidated financial statements of AVIV and those of the Partnership. AVIV’s stockholders’ equity consists of common stock, additional paid in capital and retained earnings (accumulated deficit). The Partnership’s capital consists of OP units that are owned by AVIV and other investors. The OP units held by the other investors in the Partnership are presented as part of partners’ capital in the Partnership’s consolidated financial statements and as “noncontrolling interests-operating partnership” in AVIV’s consolidated financial statements. There is no difference between the assets and liabilities or net income of AVIV and the Partnership as of and for the three and nine months ended September 30, 2014.
	The accompanying unaudited consolidated financial statements have been prepared by management in accordance with US generally accepted accounting principles (US GAAP) for interim financial information and with the instructions to Form 10-Qand Article 10 of Regulation S-X. All significant intercompany accounts and transactions have been eliminated in the consolidated financial statements.
	The Company manages its business as a single business segment as defined in Accounting Standards Codification (ASC) 280, Segment Reporting. The Company has one reportable segment consisting of investments in healthcare properties, consisting primarily of SNFs, assisted living facilities (ALFs), and other healthcare properties located in the United States. All of the Company’s properties generate similar types of revenues and expenses related to tenant rent and reimbursements and operating expenses.
	Quarterly Reporting
	The accompanying unaudited consolidated financial statements and notes of the Company as of September 30, 2014 and for the three and nine months ended September 30, 2014 and 2013 have been prepared in accordance with US GAAP for interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared under US GAAP have been condensed or omitted pursuant to US GAAP quarterly reporting rules. In the opinion of management, all adjustments considered necessary for a fair presentation of the Company’s balance sheets, statements of operations, statement of changes in equity/partners’ capital, and statements of cash flows have been included and are of a normal and recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for the Company for the years ended December 31, 2013, 2012, and 2011. The consolidated statements of operations and cash flows for the periods ended September 30, 2014 and 2013 are not necessarily indicative of full year results.
	The balance sheets at December 31, 2013 have been derived from the audited financial statements at that date, but do not include all of the information and footnotes required by US GAAP for complete financial statements. For further information, including definitions of capitalized terms not defined herein, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission.
	Estimates
	The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Cash and Cash Equivalents
	Cash and cash equivalents consist of cash and highly liquid short-term investments with original maturities of three months or less. The Company maintains cash and cash equivalents in United States banking institutions that exceed amounts insured by the Federal Deposit Insurance Corporation. The Company believes the risk of loss from exceeding this insured level is minimal.
	Real Estate Investments
	The Company periodically assesses the carrying value of real estate investments and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and circumstances exist that would suggest that assets might be impaired or that the useful lives should be modified. In the event impairment in value occurs and a portion of the carrying amount of the real estate investments will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the real estate investments and related intangibles to their estimated fair value. The estimated fair value of the Company’s rental properties is determined by using customary industry standard methods that include discounted cash flow and/or direct capitalization analysis (Level 3) or estimated cash proceeds received upon the anticipated disposition of the asset from market comparables (Level 2). As part of the impairment evaluation, the buildings in the following locations were impaired to reflect the estimated fair values (Level 2).
			For the Nine Months Ended September 30,
			2014		2013
			(in thousands)
	Willmar, MN		$	862	$	—
	Jasper, TX			1,479		—
			$	2,341	$	—
	Purchase Accounting
	The Company allocates the purchase price of facilities between net tangible and identified intangible assets acquired and liabilities assumed as a result of the Company purchasing the business and subsequently leasing the business to unrelated third party operators. The Company makes estimates of the fair value of the tangible and intangible assets and acquired liabilities using information obtained from multiple sources as a result of pre-acquisition due diligence, marketing, leasing activities of the Company’s operator base, industry surveys of critical valuation metrics such as capitalization rates, discount rates and leasing rates and appraisals (Level 3). The Company allocates the purchase price of facilities to net tangible and identified intangible assets and liabilities acquired based on their fair values in accordance with the provisions of ASC 805, Business Combinations (ASC 805). The determination of fair value involves the use of significant judgment and estimation.
	The Company determines fair values as follows:
		•		Real estate investments are valued using discounted cash flow projections that assume certain future revenue and costs and consider capitalization and discount rates using current market conditions.
		•		The Company allocates the purchase price of facilities to net tangible and identified intangible assets acquired and liabilities assumed based on their fair values.
		•		Other assets acquired and other liabilities assumed are valued at stated amounts, which approximate fair value.
		•		Assumed debt balances are valued at fair value, with the computed discount/premium amortized over the remaining term of the obligation.
	The Company determines the value of land based on third party appraisals. The fair value of in-place leases, if any, reflects: (i) above and below-market leases, if any, determined by discounting the difference between the estimated current market rent and the in-place rentals, the resulting intangible asset or liability of which is amortized to rental revenue over the remaining life of the associated lease plus any fixed rate renewal periods if applicable; (ii) the estimated value of the cost to obtain operators, including operator allowances, operator improvements, and leasing commissions, which is amortized over the remaining life of the associated lease; and (iii) an estimated value of the absorption period to reflect the value of the rents and recovery costs foregone during a reasonable lease-up period as if the acquired space was vacant, which is amortized over the remaining life of the associated lease. The Company also estimates the value of operator or other customer relationships acquired by considering the nature and extent of existing business relationships with the operator, growth prospects for developing new business with such operator, such operator’s credit quality, expectations of lease renewals with such operator, and the potential for significant, additional future leasing arrangements with such operator. The Company amortizes such value, if any, over the expected term of the associated arrangements or leases, which would include the remaining lives of the related leases. The amortization is included in the consolidated statements of operations in rental income for above or below market leases or depreciation and amortization expense for in-place lease assets. Generally, the Company’s purchase price allocation of the purchased business and subsequent leasing of the business to unrelated third party operators does not include an allocation to any intangible assets or intangible liabilities, as they are either immaterial or do not exist.
	Revenue Recognition
	Rental income is recognized on a straight-line basis over the term of the lease when collectability is reasonably assured. Differences between rental income earned and amounts due under the lease are charged or credited, as applicable, to straight-line rent receivable, net. Income recognized from this policy is titled straight-line rental income. Additional rents from expense reimbursements for insurance, real estate taxes, and certain other expenses are recognized in the period in which the related expenses are incurred and the net impact is reflected in rental income on the consolidated statements of operations.
	Below is a summary of the components of rental income for the three and nine months ended September 30, 2014 and 2013 (in thousands):
			Three Months Ended					Nine Months Ended
			September 30,					September 30,
			2014		2013			2014		2013
	Cash rental income		$	44,220	$	32,555		$	123,982	$	95,111
	Straight-line rental income (expense), net			1,727		(1,227	)		3,420		2,998
	Rental income from intangible amortization, net			132		365			539		1,097
	Total rental income		$	46,079	$	31,693		$	127,941	$	99,206
	The Company’s reserve for uncollectible operator receivables is included as a component of reserve for uncollectible loans and other receivables in the consolidated statements of operations.
	Lease Accounting
	The Company, as lessor, makes a determination with respect to each of its leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. Payments received under operating leases are accounted for in the statements of operations as rental income for actual rent collected plus or minus a straight-line adjustment for estimated minimum lease escalators. Assets subject to operating leases are reported as real estate investments in the consolidated balance sheets. For facilities leased as direct financing arrangements, an asset equal to the Company’s net initial investment is established on the balance sheet titled assets under direct financing leases. Payments received under the financing lease are bifurcated between interest income and principal amortization to achieve a consistent yield over the stated lease term using the interest method. Principal amortization (accretion) is reflected as an adjustment to the asset subject to a financing lease.
	All of the Company’s leases contain fixed or formula-based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.
	Deferred Finance Costs
	Deferred finance costs are being amortized using the straight-line method, which approximates the interest method, over the term of the respective underlying debt agreement.
	Loan Receivables
	Loan receivables consist of mortgage loans, capital improvement loans and working capital loans to operators. Mortgage loans represent the financing provided by the Company to operators or owners that are secured by mortgages on real property. Capital improvement loans represent the financing provided by the Company to perform certain capital improvements and/or to acquire furniture, fixtures, and equipment while the operator is operating the facility. Working capital loans to operators represent financing provided by the Company to operators for working capital needs that are secured with non-mortgage collateral or that are unsecured. Loan receivables are carried at their principal amount outstanding. Management periodically evaluates outstanding loans and notes receivable for collectability on a loan-by-loan basis. When management identifies potential loan impairment indicators, such as nonpayment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator, or other circumstances that may impair full execution of the loan documents, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan, the loan is written down to the present value of the expected future cash flows. Loan impairment is monitored via a quantitative and qualitative analysis including credit quality indicators and it is reasonably possible that a change in estimate could occur in the near term. As of September 30, 2014 and December 31, 2013, loan receivable reserves amounted to approximately $3.2 million and $0, respectively. No other circumstances exist that would suggest that additional reserves are necessary at the balance sheet dates other than as disclosed in Footnote 4, Loan Receivables.
	Stock-Based Compensation
	The Company follows ASC 718, Stock Compensation (ASC 718) in accounting for its stock-based payments. This guidance requires measurement of the cost of employee services received in exchange for stock compensation based on the grant-date fair value of the employee stock awards. This cost is recognized as compensation expense ratably over the employee’s requisite service period. Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized when incurred. Additionally, the Company must make estimates regarding employee forfeitures in determining compensation expense. Subsequent changes in actual experience are monitored and estimates are updated as information is available. The non-cash stock-based compensation expense incurred by the Company through September 30, 2014 is summarized in Footnote 12, Equity Compensation Plan.
	Fair Value of Financial Instruments
	ASC 820, Fair Value Measurements and Disclosures (ASC 820), establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels are defined as follows:
		•		Level 1—Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets;
		•		Level 2—Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument; and
		•		Level 3—Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
	Cash and cash equivalents are reflected in the accompanying consolidated balance sheets at amounts considered by management to reasonably approximate fair value. Management estimates the fair value of its long-term debt using a discounted cash flow analysis based upon the Company’s current borrowing rate for debt with similar maturities and collateral securing the indebtedness. The Company had outstanding secured loans, unsecured notes payable, and a line of credit with a carrying value of approximately $840.9 million and $686.4 million as of September 30, 2014 and December 31, 2013, respectively. The fair values of debt as of September 30, 2014 and December 31, 2013 were $863.6 million and $705.8 million, respectively, based upon interest rates available to the Company on similar borrowings (Level 3). Management estimates the fair value of its loan receivables using a discounted cash flow analysis based upon the Company’s current interest rates for loan receivables with similar maturities and collateral securing the indebtedness. The Company had outstanding loan receivables with a carrying value of approximately $43.3 million and $41.7 million as of September 30, 2014 and December 31, 2013, respectively. The fair values of loan receivables as of September 30, 2014 and December 31, 2013 approximate their carrying value based upon interest rates available to the Company on similar borrowings.
	Income Taxes
	For federal income tax purposes, the Company elected, with the filing of its initial Form 1120 REIT, U.S. Income Tax Return for U.S. Real Estate Investment Trusts, to be taxed as a REIT effective as of the Company’s taxable year ending December 31, 2010. To qualify as a REIT, the Company must meet certain organizational, income, asset and distribution tests. The Company currently is in compliance with these requirements and intends to maintain REIT status. If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to federal income taxes at regular corporate rates (including any applicable alternative minimum tax) and may not elect REIT status for four subsequent years. However, the Company may still be subject to federal excise tax. In addition, the Company may be subject to certain state and local income and franchise taxes. Historically, the Company and its predecessor have generally only incurred certain state and local income and franchise taxes, but these amounts were immaterial in each of the periods presented. Prior to September 2010, the Partnership was taxed as a limited partnership, and the consolidated operating results were included in the income tax returns of the individual partners. No uncertain income tax positions exist as of September 30, 2014 or December 31, 2013.
Noncontrolling Interests—Operating Partnership / Partnership Units
Noncontrolling interests—operating partnership, as presented on AVIV’s consolidated balance sheets, represent OP units held by individuals and entities other than AVIV.
Noncontrolling interests—operating partnership, which can be settled in cash or, at the REIT’s election, by issuance of unregistered shares of AVIV’s common stock, are reported in the equity section of the consolidated balance sheets of AVIV. They are adjusted for income, losses and distributions allocated to OP units not held by AVIV. Adjustments to noncontrolling interests—operating partnership are recorded to reflect increases or decreases in the ownership of the Partnership by holders of OP units as a result of the redemptions of OP units for cash or, at the election of AVIV, in exchange for shares of AVIV’s common stock.
Prior to the IPO, the capital structure of the Company’s operating partnership consisted of six classes of partnership units, each of which had different capital accounts and each of which was entitled to different distributions. In connection with the IPO, each class of units of the Partnership was converted into an aggregate of 11,938,420 OP units held by investors other than AVIV in the Partnership. As of September 30, 2014, there were 11,416,426 OP units outstanding.
Earnings Per Share of the REIT
Basic earnings per share is calculated by dividing the net income allocable to common shares for the period by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated by dividing the net income allocable to common shares for the period by the weighted average number of common and dilutive securities outstanding during the period.
Earnings Per Unit of the Partnership
Basic earnings per unit is calculated by dividing the net income allocable to units for the period by the weighted average number of OP units outstanding during the period. Diluted earnings per unit is calculated by dividing the net income allocable to OP units for the period by the weighted average number of units and dilutive securities outstanding during the period.
Risks and Uncertainties
The Company is subject to certain risks and uncertainties affecting the healthcare industry as a result of healthcare legislation and continuing regulation by federal, state, and local governments. Additionally, the Company is subject to risks and uncertainties as a result of changes affecting operators of nursing home facilities due to the actions of governmental agencies and insurers to limit the growth in cost of healthcare services.
Recent Accounting Pronouncements
In April 2014, the FASB issued ASU No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (ASU No. 2014-08). ASU No. 2014-08 changes the definition of a discontinued operation to include only those disposals of components of an entity that represent a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. ASU No. 2014-08 is effective prospectively for fiscal years beginning after December 15, 2014 and is available for early adoption as of January 1, 2014. The Company adopted the provisions of ASU No. 2014-08 as of January 1, 2014 and incorporated the provisions of this update to its condensed consolidated financial statements upon adoption. The adoption of ASU No. 2014-08 did not have a material impact on the Company’s financial condition or results of operations.
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which creates a new topic, Accounting Standards Codification Topic 606 (Topic 606). The standard is principle-based and provides a five-step model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This standard is effective for interim or annual periods beginning after December 15, 2016 and allows for either full retrospective or modified retrospective adoption. Early adoption of this standard is not allowed. The Company is currently evaluating the impact the adoption of Topic 606 will have on its consolidated financial statements.
In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements - Going Concern.” This update provide guidance about management’s responsibilities to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures in certain circumstances. An entity’s management, in connection with the preparation of financial statements, to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. Management’s evaluation should be based on relevant conditions and events that are known or reasonably knowable at the date the financial statements are issued. When management identifies conditions or events that raise substantial doubt about an entity’s ability to continue as a going concern, the entity should disclose information that enables users of the financial statements to understand all of the following: (1) principal conditions or events that raised substantial doubt about the entity’s ability to continue as a going concern (before consideration of management’s plans); (2) management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations; and (3) management’s plans that alleviated substantial doubt about the entity’s ability to continue as a going concern or management’s plans that are intended to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. ASU No. 2014-15 is effective for interim and annual reporting periods after December 15, 2016 and early application is permitted. The Company is currently assessing this guidance for future implementation.
Reclassifications
Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the Company’s consolidated financial position or results of operations.

Real_Estate_Assets

Real Estate Assets	9 Months Ended
	Sep. 30, 2014
Real Estate Assets	'
	3. Real Estate Assets
	2014 Acquisitions
	The Company had the following acquisitions during the nine months ended September 30, 2014 as described below:
	Month Acquired	Property Type		Location	Purchase Price
					(in thousands)
	January	SNF/ALF/ILF		MN	$	40,000
	January	SNF		TX		15,920
	March	SNF		IA		13,500
	March	SNF		KY		35,000
	April	SNF		FL		6,000
	April	SNF		TX		53,700
	May	SNF		TX		3,600
	May	SNF		CA		13,350
	June	SNF		KY		6,000
	July	SNF		MO		16,200
	July	ALF		MA		32,000
	July	SNF/ALF		MA		50,000
	September	SNF/ALF		WA/ID		83,600
						368,870
	February	Land Held for Development		TX		2,110
	July	Land Held for Development		MA		12,288
					$	383,268
	On July 10, 2014, the Company acquired three properties and two land parcels in Massachusetts for a purchase price of $94.3 million. Sidney and Evelyn Insoft, the parents of Steven Insoft, the Company’s President and Chief Operating Officer, jointly hold a 50% equity interest in the sellers of the properties, representing a gross economic interest in the sale of approximately $47.1 million. The Company believes that the terms of the acquisition were fair and reasonable and reflect terms that the Company would expect to obtain in an arm’s length transaction for comparable properties.
	The following table illustrates the effect on total revenues and net income as if the Company had consummated the acquisitions as of January 1, 2013 (in thousands, unaudited):
		For the Three Months Ended					For the Nine Months Ended
		September 30,					September 30,
		2014			2013		2014		2013
	Total revenues	$	48,795		$	41,831	$	145,811	$	129,480
	Net income		13,874			16,442		43,838		31,173
	For the three and nine months ended September 30, 2014, revenues attributable to the acquired assets in 2014 were approximately $7.5 million and $13.5 million, respectively, and net income attributable to the acquired assets was approximately $4.5 million and $7.2 million, respectively, recognized in the consolidated statements of operations.
	Transaction-related costs are not expected to have a continuing significant impact on our financial results and therefore have been excluded from these pro forma results. Related to the above acquisitions, the Company incurred $0.7 million and $2.4 million of transaction costs for the three and nine months ended September 30, 2014, respectively.
	In accordance with ASC 805, the Company allocated the approximate net purchase price paid for these properties acquired in 2014 as follows (in thousands):
	Land	$	33,390
	Buildings and improvements		310,390
	Furniture, fixtures and equipment		25,090
	Construction in progress and land held for development		14,398
	Borrowings and available cash	$	383,268
	The Company’s purchase price allocation for the 2014 acquisitions and subsequent leasing of assets does not include an allocation to any intangible assets or intangible liabilities, as these amounts are either immaterial or do not exist.
	The Company considers renewals on above- or below-market leases when ascribing value to the in-place lease intangible liabilities at the date of a property acquisition. In those instances where the renewal lease rate pursuant to the terms of the lease does not adjust to a current market rent, the Company evaluates whether the stated renewal rate is above or below current market rates and considers the past and current operations of the property, the current rent coverage ratio of the operator, and the number of years until potential renewal option exercise. If renewal is considered probable based on these factors, an additional lease intangible liability is recorded at acquisition and amortized over the renewal period.
	2014 Dispositions
	For the three months ended September 30, 2014, the Company disposed of five properties for a total sales price of $0.8 million, and the Company recognized a net loss on sale of approximately $2.4 million. The total sales price and net loss are net of transaction costs incurred in relation to the closings at the time of disposition.
	For the nine months ended September 30, 2014, the Company disposed of seven properties for a total sales price of $1.4 million, and the Company recognized a net loss on sale of approximately $2.5 million. The total sales price and net loss are net of transaction costs incurred in relation to the closings at the time of disposition.
	Construction in Process
	The following summarizes the Company’s construction in progress and land held for development during the nine months ended September 30, 2014 (in thousands):
		September 30, 2014
	Beginning balance, January 1	$	23,292
	Additions		31,170
	Placed in service		(20,041	)
		$	34,421
	During 2014 and 2013, the Company capitalized expenditures for improvements related to various construction and reinvestment projects. In 2014, the Company placed into service six completed investment projects at six properties located in California, Pennsylvania, Texas and Indiana. In 2013, the Company placed into service one completed investment project at one property located in California. In accordance with ASC 835, Capitalization of Interest (ASC 835), the Company capitalizes interest based on the average cash balance of construction in progress for the period using the weighted-average interest rate on all outstanding debt, which approximated 6.0% for the three and nine months ended September 30, 2014. The balance of capitalized interest within construction in progress at September 30, 2014 and December 31, 2013 was $0.7 million and $0.8 million, respectively. The amount capitalized during the three and nine months ended September 30, 2014 and 2013, relative to interest incurred, was $0.2 million, $0.5 million, $0.2 million and $0.4 million, respectively.

Loan_Receivables

Loan Receivables	9 Months Ended
	Sep. 30, 2014
Loan Receivables	'
	4. Loan Receivables
	The following summarizes the Company’s loan receivables, net activity during the nine months ended September 30, 2014 (in thousands):
		September 30, 2014
		Mortgage			Capital			Working			Total
		Loans			Improvement			Capital			Loans
					Loans			Loans
	Beginning balance, January 1, 2014	$	28,316		$	4,580		$	8,790		$	41,686
	New loans issued		4,762			—			7,648			12,410
	Reserve for uncollectible loans		—			—			(3,211	)		(3,211	)
	Loan amortization and repayments		(5,394	)		(760	)		(1,459	)		(7,613	)
		$	27,684		$	3,820		$	11,768		$	43,272
	The following summarizes the Company’s interest income on loans and financing leases for the three and nine months ended September 30, 2014 and 2013 (in thousands):
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
	Mortgage loans	$	456		$	472		$	1,364		$	1,208
	Capital improvement loans		66			117			267			417
	Working capital loans		211			177			529			556
	Direct financing lease		368			365			1,103			1,091
	Total interest on loans and financing lease	$	1,101		$	1,131		$	3,263		$	3,272
	The Company’s reserve on a loan-by-loan basis for uncollectible loan receivables balances at September 30, 2014 and December 31, 2013 was approximately $3.2 million and $0, respectively, and any movement in the reserve is reflected in reserve for uncollectible loan and other receivables in the consolidated statements of operations. The gross balance of loan receivables for which a reserve on a loan-by-loan basis for uncollectible loan receivables has been applied was approximately $3.2 million and $0, at September 30, 2014 and December 31, 2013, respectively.
	During 2014 and 2013, the Company funded loans for mortgage loans, capital improvement purposes, and working capital purposes to various operators. All loans held by the Company accrue interest and are recorded as interest income unless the loan is deemed impaired in accordance with Company policy. The payments received from the operator cover both interest accrued as well as amortization of the principal balance due. Any payments received from the operator made outside of the normal loan amortization schedule are considered principal prepayments and reduce the outstanding loan receivables balance.

Deferred_Finance_Costs

Deferred Finance Costs	9 Months Ended
	Sep. 30, 2014
Deferred Finance Costs	'
	5. Deferred Finance Costs
	The following summarizes the Company’s deferred finance costs at September 30, 2014 and December 31, 2013 (in thousands):
		September 30,			December 31,
		2014			2013
	Gross amount	$	25,531		$	21,881
	Accumulated amortization		(7,880	)		(5,238	)
	Net	$	17,651		$	16,643
	For the three and nine months ended September 30, 2014, the Company wrote-off deferred financing costs of $0 and $0.8 million, respectively, with approximately $0 and $0.3 million, respectively, of accumulated amortization associated with the refinancing of the Company’s secured Revolving Credit Facility (as defined below) to a new unsecured revolving credit facility for the net recognition as loss on extinguishment of debt of approximately $0 and $0.5 million, respectively.

Intangible_Assets_and_Liabilit

Intangible Assets and Liabilities	9 Months Ended
	Sep. 30, 2014
Intangible Assets and Liabilities	'
	6. Intangible Assets and Liabilities
	The following summarizes the Company’s intangible assets and liabilities classified as part of other assets or other liabilities at September 30, 2014 and December 31, 2013, respectively (in thousands):
		Assets
		September 30, 2014							December 31, 2013
		Gross Amount		Accumulated			Net		Gross Amount		Accumulated			Net
				Amortization							Amortization
	Above market leases	$	5,512	$	(2,830	)	$	2,682	$	6,437	$	(3,452	)	$	2,985
	In-place lease assets		652		(179	)		473		652		(130	)		522
	Operator relationship		212		(47	)		165		212		(34	)		178
		$	6,376	$	(3,056	)	$	3,320	$	7,301	$	(3,616	)	$	3,685
		Liabilities
		30-Sep-14							31-Dec-13
		Gross Amount		Accumulated			Net		Gross Amount		Accumulated			Net
				Amortization							Amortization
	Below market leases	$	12,933	$	(6,212	)	$	6,721	$	17,623	$	(10,059	)	$	7,564
	Amortization expense for in-place lease assets and operator relationship was $0.02 million, $0.06 million, $0.02 million and $0.06 million for the three and nine months ended September 30, 2014 and 2013, respectively, and is included as a component of depreciation and amortization in the consolidated statements of operations. Amortization expense for the above market leases intangible asset for the three and nine months ended September 30, 2014 and 2013 was approximately $0.09 million, $0.3 million, $0.1 million and $0.4 million, respectively, and is included as a component of rental income in the consolidated statements of operations. Accretion for the below market leases intangible liability for the three and nine months ended September 30, 2014 and 2013 was approximately $0.2 million, $0.8 million, $0.5 million and $1.5 million, respectively, and is included as a component of rental income in the consolidated statements of operations.
	For the three and nine months ended September 30, 2014, the Company wrote-off fully amortized above market leases intangible assets of approximately $0.3 million and $0.9 million, respectively, and fully amortized below market leases intangible liabilities of approximately $0.3 million and $4.7 million, respectively, for a net recognition of $0 and $0, respectively, in rental income from intangible amortization. These write-offs were the result of fully amortized assets and fully accreted liabilities.

Leases

Leases	9 Months Ended
	Sep. 30, 2014
Leases	'
	7. Leases
	As of September 30, 2014, the Company’s portfolio of investments consisted of 313 healthcare facilities, located in 29 states and operated by 38 third party operators. At September 30, 2014, approximately 53.6% (measured as a percentage of total assets) were leased by five private operators: Maplewood (13.1%), Saber Health Group (11.4%), EmpRes (11.1%), Daybreak Healthcare (9.6%), and Fundamental (8.4%). No other operator represents more than 5.3% of the Company’s total assets. The five states in which the Company had its highest concentration of total assets were Texas (16.9%), Ohio (12.1%), California (10.7%), Washington (7.0%), and Connecticut (6.5%), at September 30, 2014.
	For the nine months ended September 30, 2014, the Company’s rental income from operations totaled approximately $127.9 million, of which approximately $17.0 million was from Daybreak Healthcare (13.3%), $16.3 million from Saber Health Group (12.7%), and $9.9 million from EmpRes (7.7%). No other operator generated more than 7.5% of the Company’s rental income from operations for the nine months ended September 30, 2014.

Debt

Debt	9 Months Ended
	Sep. 30, 2014
Debt	'
	8. Debt
	The Company’s secured loans, unsecured notes payable and line of credit consisted of the following (in thousands):
		September 30,		December 31,
		2014		2013
	HUD loan (interest rate of 5.00% on September 30, 2014 and December 31, 2013), inclusive of a $2.4 million and $2.4 million premium balance at September 30, 2014 and December 31, 2013, respectively	$	13,478	$	13,654
	2019 Notes (interest rate of 7.75% on September 30, 2014 and December 31, 2013), inclusive of $2.4 million and $2.8 million net premium balance, respectively		402,410		402,752
	2021 Notes (interest rate of 6.00% on September 30, 2014 and December 31, 2013)		250,000		250,000
	Credit Facility (interest rate of 1.85% on September 30, 2014)		175,000		—
	Revolving Credit Facility (interest rate of 2.52% on December 31, 2013)		—		20,000
	Total	$	840,888	$	686,406
	2019 Notes
	On February 4, 2011, April 5, 2011 and March 28, 2012, the Partnership and Aviv Healthcare Capital Corporation (the Issuers) issued $200 million, $100 million and $100 million of 7 3⁄4% Senior Notes due in 2019 (the 2019 Notes), respectively. The REIT is a guarantor of the Issuers’ 2019 Notes. The 2019 Notes are unsecured senior obligations of the Issuers and will mature on February 15, 2019 and bear interest at a rate of 7.75% per annum, payable semiannually to holders of record at the close of business on the February 1 or the August 1 immediately preceding the interest payment date on February 15 and August 15 of each year, commencing August 15, 2011. Premiums of approximately $2.75 million and $1.0 million were associated with the offerings of the $100 million of 2019 Notes on April 5, 2011 and the $100 million of 2019 Notes on March 28, 2012, respectively. The premiums will be amortized as an adjustment to the yield on the 2019 Notes over their term. The Company used the proceeds to, amongst other things, pay down the outstanding balance of previous credit facilities during 2012.
	2021 Notes
	On October 16, 2013, the Issuers issued $250 million of 6% Senior Notes due in 2021 (2021 Notes). The REIT is a guarantor of the Issuers’ 2021 Notes. The 2021 Notes are unsecured senior obligations of the Issuers and will mature on October 15, 2021 and bear interest at a rate of 6.00% per annum, payable semiannually to holders of record at the close of business on the April 1 or the October 1 immediately preceding the interest payment date on April 15 and October 15 of each year, commencing April 15, 2014. The Company used the net proceeds to, amongst other things, pay down approximately $135.0 million of the outstanding indebtedness under the Revolving Credit Facility during 2013.
	Credit Facility
	On March 26, 2013, the Company, through Aviv Financing IV, entered into a $300 million secured revolving credit facility and $100 million term loan with Bank of America, N.A. (collectively, the Revolving Credit Facility). On April 16, 2013, the Company converted the entire $100 million term loan into a secured revolving credit facility, thereby terminating the term loan and any availability thereunder and increasing the amount available under the secured revolving credit facility from $300 million to $400 million. On each payment date, the Company paid interest only in arrears on any outstanding principal balance. The interest rate was based on LIBOR plus a margin of 235 basis points to 300 basis points depending on the Company’s leverage ratio. Additionally, an unused fee equal to 50 basis points per annum of the daily unused balance on the Revolving Credit Facility was payable quarterly in arrears.
	On May 14, 2014, the Company terminated the Revolving Credit Facility and, through the Partnership, entered into a new $600 million unsecured revolving credit facility (the Credit Facility). The Credit Facility has an interest rate that ranges from 170 to 225 basis points over LIBOR depending on the Company’s consolidated leverage and a maturity date of May 14, 2018. The Credit Facility can be extended for an additional year at the Company’s option, subject to the satisfaction of certain conditions, and contains an accordion feature increasing the borrowing capacity to $800 million. As of September 30, 2014, the Credit Facility had a balance of $175.0 million.
	Other Loans
	On June 15, 2012, a subsidiary of Aviv Financing III assumed a HUD loan with a balance of approximately $11.5 million. Interest is at a fixed rate of 5.00%. The loan originated in November 2009 with a maturity date of October 1, 2044 and is based on a 35-year amortization schedule. The Company is obligated to pay the remaining principal and interest payments of the loan. A premium of $2.5 million was associated with the assumption of debt and will be amortized as an adjustment to interest expense on the HUD loan over its term.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies	'
	9. Commitments and Contingencies
	The Company has contractual arrangements with three operators in six of its facilities to reimburse any liabilities, obligations or claims of any kind or nature resulting from the actions of the former operators in such facilities. The Company is obligated to reimburse the fees to the operator if and when the operator incurs such expenses associated with certain Indemnified Events, as defined therein. The total possible obligation for these fees is estimated to be $2.6 million, of which approximately $2.1 million has been paid to date. The remaining $0.5 million was accrued as a component of other liabilities in the consolidated balance sheets.
	The Company has purchase options with one of its tenants that are not exercisable by the tenant until January 1, 2017 for five properties, January 1, 2019 for two properties, and January 1, 2022 for five properties. If the 2017 option is not exercised, the tenant loses the right to exercise the 2019 option and the 2022 option. If the 2017 option is exercised, but the 2019 option is not exercised, the tenant loses the right to exercise the 2022 option. The purchase options call for the purchase price, as defined, to be determined at a future date. In addition, the Company has purchase options with four tenants on five properties that are exercisable by the applicable tenant at various times during the terms of the respective leases. Two of these options are exercisable at a predetermined purchase price and the remaining three call for a purchase price to be determined at a future date.
	The Company is involved in various unresolved legal actions and proceedings, which arise in the normal course of our business. Although the outcome of a particular proceeding can never be predicted, we do not believe that the result of any of these other matters will have a material adverse effect on our business, operating results, liquidity or financial position.

Noncontrolling_InterestsOperat

Noncontrolling Interests-Operating Partnership / OP Units	9 Months Ended
	Sep. 30, 2014
Noncontrolling Interests-Operating Partnership / OP Units	'
	10. Noncontrolling Interests—Operating Partnership / OP Units
	Noncontrolling interests—operating partnership, as presented on AVIV’s consolidated balance sheets, represent the OP units held by individuals and entities other than AVIV. Accordingly, the following discussion related to noncontrolling interests—operating partnership of the REIT refers equally to OP units of the Partnership.
	Holders of OP units are entitled to receive distributions in a per unit amount equal to the per share dividends made with respect to each share of AVIV’s common stock, if and when AVIV’s Board of Directors declares such a dividend. Holders of OP units have the right to tender their OP units for redemption, in an amount equal to the fair market value of AVIV’s common stock. AVIV may elect to redeem tendered OP units for cash or for shares of AVIV’s common stock. During the three and nine months ended September 30, 2014, OP unitholders redeemed a total of 26,885 and 199,856 OP units in exchange for an equal number of shares of common stock of AVIV.

Stockholders_Equity_of_the_REI

Stockholders' Equity of the REIT and Partners' Capital of the Partnership	9 Months Ended
	Sep. 30, 2014
Stockholders' Equity of the REIT and Partners' Capital of the Partnership	'
	11. Stockholders’ Equity of the REIT and Partners’ Capital of the Partnership
	Distributions accrued are summarized as follows for the three months ended September 30, (in thousands):
			Class A				Class B			Class C		Class D		Class F		OP Units		REIT Shares
	2014		$	—			$	—		$	—	$	—	$	—	$	4,110	$	17,009
	2013		$	—			$	—		$	—	$	—	$	—	$	4,298	$	13,435
	Distributions accrued are summarized as follows for the nine months ended September 30, (in thousands):
			Class A				Class B			Class C		Class D		Class F		OP Units		REIT Shares
	2014		$	—			$	—		$	—	$	—	$	—	$	12,374	$	47,666
	2013		$	2,797			$	97		$	146	$	—	$	554	$	8,882	$	34,286
	In connection with the IPO, the existing classes of limited partnership units of the Partnership were converted into an aggregate of 21,653,813 OP units held by the REIT and 11,938,420 OP units held by other investors of the Partnership. As a result, Class A, B, C, D and F Units are no longer outstanding, and the Partnership has had a single class of OP units since March 26, 2013. As noted above, the OP units held by other investors in the Partnership are redeemable for cash or, at the REIT’s election, unregistered shares of the REIT’s common stock on a one-for-one basis.
	The weighted-average units outstanding for each class of units are summarized as follows for the three months ended September 30:
			Class A				Class B			Class C		Class D		Class F		OP Units		REIT Shares
	2014			—				—			—		—		—		11,419,777		47,213,612
	2013			—				—			—		—		—		11,938,420		37,271,714
	The weighted-average units outstanding for each class of units are summarized as follows for the nine months ended September 30:
			Class A				Class B			Class C		Class D		Class F		OP Units		REIT Shares
	2014			—				—			—		—		—		11,478,543		43,576,705
	2013			4,193,031				1,408,305			—		2,506		835,958		8,221,330		32,408,843
	During the nine months ended September 30, 2014 and 2013, the Company had the following equity and capital activity:
		•		AVIV issued an aggregate of 16,361 and 0 shares of common stock in connection with the Company’s annual grant of unrestricted stock to management, respectively;
		•		AVIV issued an aggregate of 16,618 and 70,000 shares of common stock in connection with the Company’s annual grant of unrestricted and restricted stock to its Board of Directors, respectively;
		•		AVIV reserved for issuance an aggregate of 156,397 and 0 shares of common stock in connection with the Company’s annual grant of restricted stock to employees and issuance of restricted stock to a new employee, respectively;
		•		AVIV issued 15,180,000 shares in connection with the IPO on March 26, 2013 that resulted in proceeds to the Company, net of underwriting discounts, commissions, advisory fees and other offering costs of $282.3 million;
		•		AVIV issued 9,200,000 shares on April 15, 2014 in connection with an underwritten public offering of shares of AVIV’s common stock that resulted in proceeds to the Company, net of underwriting discounts, commissions, advisory fees and other offering costs of $211.3 million (the Equity Offering);
		•		OP unit holders redeemed a total of 199,856 and 0 OP units in exchange for an equal number of shares of AVIV’s common stock, respectively; and
		•		AVIV issued 174,467 and 0 shares of common stock in connection with an option exercise, respectively.
	For the nine months ended September 30, 2014, AVIV declared the following cash dividends on its common stock, and the Partnership declared equivalent distributions on its OP units:
	Declaration Date		Record		Amount Per				Dividend Payment
			Date		Share				Date
	March 18, 2014		March 31, 2014		$	0.36			April 11, 2014
	May 27, 2014		27-Jun-14		$	0.36			July 11, 2014
	29-Jul-14		September 26, 2014		$	0.36			October 10, 2014
	Total				$	1.08

Equity_Compensation_Plan

Equity Compensation Plan	9 Months Ended
	Sep. 30, 2014
Equity Compensation Plan	'
	12. Equity Compensation Plan
	Prior to September 2010, the Partnership had established an officer incentive program linked to its future value. Class D Units were periodically granted to employees of AAM. Part of the Class D Units are defined as performance-based awards under ASC 718 and require employment of the recipient on the date of sale, disposition, or refinancing. If the employee is no longer employed on such date, the award is forfeited. The remainder of the Class D Units were time-based awards under ASC 718 and such fair value determined on the grant date was recognized over the vesting period. On March 26, 2013, the performance component Class D Units vested and along with time based units were converted to OP units in connection with the IPO, and $0.9 million of expense was recognized.
	Restricted Stock Grants
	On March 26, 2013 the Company adopted the Aviv REIT, Inc. 2013 Long-Term Incentive Plan (the LTIP). The purpose of the LTIP is to attract and retain qualified persons upon whom, in large measure, the Company’s sustained progress, growth and profitability depend, to motivate the participants to achieve long-term Company goals and to align the participants’ interests with those of other stockholders by providing them with a proprietary interest in the Company’s growth and performance. The Company’s executive officers, employees, consultants and non-employee directors are eligible to participate in the LTIP. Under the plan, 2,000,000 shares of the Company’s common stock are available for issuance. The shares can be issued as restricted stock awards (RSAs) or as restricted stock units (RSUs).
	During 2013, the Company issued 23,250 shares and 47,250 RSAs subject to a vesting period. During the nine months ended September 30, 2014, 15,750 of the 47,250 RSAs vested. Additionally, the Company issued 226,585 RSUs, of which 17,470 were subsequently forfeited prior to the year ended December 31, 2013. Of these 226,585 RSUs, 16,361 shares were issued and vested in the nine months ended September 30, 2014 and an additional 7,779 RSUs were forfeited. Some of these RSUs are subject to time vesting, and some are subject to performance vesting. The time-based RSUs generally vest over a period of two to three years, subject to the employee’s continued employment with the Company. The performance-based RSUs are earned on the basis of Total Shareholder Return (TSR) on the Company’s stock compared to the TSR of a defined group of peer companies. The first installment of the performance-based RSUs are based on the companies comprising the NAREIT Equity Index and the companies comprising the Bloomberg Healthcare REIT Index for the performance period beginning on the date of the IPO and ending December 31, 2014. The second installment is based on the companies comprising the NAREIT Equity Index and the companies comprising the Bloomberg Healthcare REIT Index for the performance period beginning on the date of the IPO and ending December 31, 2015. If the service and performance conditions are met, approximately half of the RSUs will vest on December 31, 2014, and the remaining will vest on December 31, 2015. The RSUs carry dividend equivalent rights that are subject to the same vesting terms as the underlying RSUs.
	During the nine months ended September 30, 2014, the Company issued 156,397 RSUs of which 18,445 have been forfeited. Some of these RSUs are subject to time vesting, and some are subject to performance vesting. The time-based RSUs cliff vest over a period of three years, subject to the employee’s continued employment with the Company. The performance-based RSUs cliff vest on the basis of TSR on the Company’s stock compared to the TSR of a defined group of peer companies. Approximately half of the performance-based RSUs are based on the companies comprising the NAREIT Equity Index for the performance period beginning on January 1, 2014 and ending December 31, 2016. Approximately half are based on the companies in the Bloomberg Healthcare REIT Index for the performance period beginning on January 1, 2014 and ending December 31, 2016. If the service and performance conditions are met, the RSUs will vest on December 31, 2016.
	For the three and nine months ended September 30, 2014 and 2013, the Company recognized total non-cash stock-based compensation expense related to the LTIP of $0.9 million, $3.6 million, $0.5 million and $0.6 million, respectively.
	Restricted stock grants vest over specified periods of time as long as the employee remains with the Company. The following table sets forth the number of unvested shares of restricted stock and the weighted average fair value of these shares at the date of grant:
			Nine Months Ended
			September 30, 2014					September 30, 2013
			Shares of			Weighted Average		Shares of		Weighted Average
			Restricted Stock			Fair Value of		Restricted Stock		Fair Value of
						Date of Grant				Date of Grant
	Unvested balance at January 1			256,092		$	29.83		—	$	—
	Granted			172,915		$	26.55		182,092	$	33.1
	Vested (1)			(40,055	)	$	23.08		—	$	—
	Forfeited			(26,724	)	$	30.53		—	$	—
	Unvested balance at September 30			362,228		$	28.96		182,092	$	33.1
	-1	Includes 7,944 shares which were used to settle minimum employee withholding tax obligations for one employee of approximately $0.2 million in 2014. A net of 32,111 shares of common stock were delivered in the nine months ended September 30, 2014.
	As of September 30, 2014, total unearned compensation on restricted stock was $6.5 million, and the weighted average vesting period was 1.76 years.
	Option Awards
	On September 17, 2010, the Company adopted the 2010 Management Incentive Plan (the MIP), which provides for the grant of option awards. Two-thirds of the options granted under the MIP were performance-based awards whose criteria for vesting is tied to a future liquidity event (as defined therein) and also contingent upon meeting certain return thresholds (as defined therein). The grant date fair value associated with all performance-based award options of the Company aggregated to approximately $7.4 million at the time of the IPO. One third of the options granted under the MIP were time based awards and the service period for these options is four years with shares vesting at a rate of 25% ratably from the grant date.
	In connection with the IPO, all options outstanding under the MIP, representing options to purchase 5,870,138 shares with a weighted average exercise price of $17.47 per share, became fully-vested. In addition, recipients were entitled to receive dividend equivalents on their options awarded under the MIP. Dividend equivalents were paid on time-based options on (i) the date of vesting, with respect to any portion of a time-based option that was unvested on the date the dividend equivalent was accrued, and (ii) the last day of the calendar quarter in which such dividends were paid to stockholders, with respect to any portion of a time-based option vested as of the date the dividend equivalent was accrued. Dividend equivalents accrued and unpaid prior to the consummation of the IPO in the approximate amount of $14.8 million were paid in shares of common stock, net of applicable withholding of approximately $6.8 million, in an amount based on the IPO price of the common stock. No dividend equivalents will be paid for any MIP options with respect to periods after the date of the IPO by the Company.
	In connection with the IPO, the holders of option awards under the MIP received a new class of units of LG Aviv L.P., the legal entity through which Goldberg Lindsay & Co., LLC holds its interest in the REIT, equal to the number of options held by such persons immediately prior to the consummation of the IPO. Under the limited partnership agreement of LG Aviv L.P., the units are entitled to receive an aggregate distribution amount equal to 14.9% of the dividend distributions declared and received by LG Aviv L.P. after the consummation of the IPO in respect of its shares of common stock. The distribution amount will be paid by LG Aviv L.P. ratably to each holder of such units on the distribution date in the proportion that the total number of units held by such holder bears to the total outstanding units of the same class. Any unit payments will be paid, if at all, on the earlier of (i) the last day of the calendar quarter in which dividends were paid to the Company stockholders and (ii) three business days following the holder’s termination of employment with the Company. For the nine months ended September 30, 2014, $3.4 million was paid by LG Aviv L.P. to the holders of such units.
	The following table represents the time- and performance-based option awards activity for the nine months ended September 30, 2014 and 2013:
			Nine Months Ended
			September 30,			September 30,
			2014			2013
	Outstanding at January 1			5,870,138			1,956,713
	Exercised			(174,467	)		—
	Awards vested at IPO			—			3,913,425
	Outstanding at September 30			5,695,671			5,870,138
	Options exercisable at end of period			5,695,671			—
	Weighted average fair value of options granted		$	2.2		$	2.2
	The following table represents the time- and performance-based option awards outstanding cumulatively life-to-date for the nine months ended September 30, 2014 and 2013 as well as other MIP data:
			2014		2013
	Range of exercise prices		$16.56-$18.87		$16.56 - $18.87
	Outstanding		5,695,671		5,870,138
	Remaining contractual life (years)		6.52		7.55
	Weighted average exercise price		$17.44		$17.47
	The Company has used the Black-Scholes option pricing model to estimate the grant date fair value of the options. In connection with the IPO, all options outstanding under the MIP became fully vested, and the plan was retired. There were no options awarded in the nine months ended September 30, 2014 or 2013.
	The Company recorded non-cash compensation expenses of approximately $0, $0, $0, and $9.0 million for the three and nine months ended September 30, 2014 and 2013, respectively, related to the time and performance based stock options accounted for as equity awards, as a component of general and administrative expenses in the consolidated statements of operations.
	At September 30, 2014, there is no unrecognized compensation cost to be recognized related to the option awards.
	Dividend equivalent rights associated with the MIP that became payable upon vesting amounted to $0, $0, $0, and $15.4 million for the three and nine months ended September 30, 2014 and 2013, respectively.

Earnings_Per_Common_Share_of_t

Earnings Per Common Share of the REIT	9 Months Ended
	Sep. 30, 2014
Earnings Per Common Share of the REIT	'
	13. Earnings Per Common Share of the REIT
	The following table shows the amounts used in computing the basic and diluted earnings per common share (in thousands except for share and per share amounts).
		For the Three Months Ended						For the Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
	Numerator for earnings per common share—basic:
	Net income	$	12,035		$	10,067		$	31,951		$	12,031
	Net income allocable to noncontrolling interests		(2,344	)		(2,446	)		(6,662	)		(3,236	)
	Numerator for earnings per common share—basic	$	9,691		$	7,621		$	25,289		$	8,795
	Numerator for earnings per common share—diluted:
	Numerator for earnings per common share—basic	$	9,691		$	7,621		$	25,289		$	8,795
	Net income allocable to noncontrolling interests—OP units		2,344			2,446			6,662			2,228
	Numerator for earnings per common share—diluted	$	12,035		$	10,067		$	31,951		$	11,023
	Denominator for earnings per common share—basic and diluted:
	Denominator for earnings per common share—basic		47,213,612			37,271,714			43,576,705			32,408,843
	Effect of dilutive securities:
	Noncontrolling interests—OP units		11,419,777			11,938,420			11,478,543			8,221,330
	Stock options		2,155,075			1,599,302			1,953,632			1,454,735
	Restricted stock units		179,403			29,093			118,904			16,169
	Denominator for earnings per common share—diluted		60,967,867			50,838,529			57,127,784			42,101,077
	Basic earnings per common share
	Net income allocable to common stockholders	$	0.21		$	0.2		$	0.58		$	0.27
	Diluted earnings per common share
	Net income allocable to common stockholders	$	0.2		$	0.2		$	0.56		$	0.26
Aviv Healthcare Properties Limited Partnership	'
Earnings Per Common Share of the REIT	'
	14. Earnings Per Unit of the Partnership
	The following table shows the amounts used in computing the basic and diluted earnings per unit (in thousands except for unit and per unit amounts).
		For the Three Months Ended						For the Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
	Numerator for earnings per unit—basic:
	Net income	$	12,035		$	10,067		$	31,951		$	12,031
	Net income allocable to limited partners		—			—			—			(1,008	)
	Numerator for earnings per unit—basic:	$	12,035		$	10,067		$	31,951		$	11,023
	Numerator for earnings per unit— diluted:
	Numerator for earnings per unit—diluted	$	12,035		$	10,067		$	31,951		$	11,023
	Denominator for earnings per unit— basic and diluted:
	Denominator for basic earnings per unit— basic		58,633,389			49,210,134			55,055,248			40,630,173
	Effective dilutive securities:
	Stock options		2,155,075			1,599,302			1,953,632			1,454,735
	Restricted stock units		179,403			29,093			118,904			16,169
	Denominator for earnings per unit—diluted		60,967,867			50,838,529			57,127,784			42,101,077
	Basic earnings per unit:
	Net income allocable to units	$	0.21		$	0.2		$	0.58		$	0.27
	Diluted earnings per unit:
	Net income allocable to units	$	0.2		$	0.2		$	0.56		$	0.26

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events	'
	15. Subsequent Events
	On October 1, 2014, the Company acquired one property in Kentucky for a purchase price of $4.6 million from an unrelated third party.
	On October 17, 2014, the Company acquired two properties in Texas for a purchase price of $28.5 million from an unrelated third party.
	On October 30, 2014, AVIV and the Partnership entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Omega Healthcare Investors, Inc. (“Omega”), OHI Healthcare Properties Holdco, Inc., a wholly-owned subsidiary of Omega (“Merger Sub”), and OHI Healthcare Properties Limited Partnership, L.P., a wholly-owned subsidiary of Omega. The Merger Agreement provides for the merger of AVIV with and into Merger Sub (the “Merger”), with Merger Sub surviving as a wholly-owned subsidiary of Omega. At the effective time of the Merger, and subject to the terms and conditions set forth in the Merger Agreement, each outstanding share of Aviv common stock will be converted into the right to receive 0.90 shares of Omega common stock.

Condensed_Consolidating_Inform

Condensed Consolidating Information	9 Months Ended
	Sep. 30, 2014
Condensed Consolidating Information	'
	16. Condensed Consolidating Information
	AVIV and certain of the Partnership’s direct and indirect wholly owned subsidiaries (the Subsidiary Guarantors) fully and unconditionally guaranteed, on a joint and several basis, the obligation to pay principal and interest with respect to the Issuers’ 2019 Notes and 2021 Notes issued in February 2011, April 2011, March 2012 and October 2013. The 2019 Notes and 2021 Notes were issued by the Partnership and Aviv Healthcare Capital Corporation. Separate financial statements of the guarantors are not provided, as the consolidating financial information contained herein provides a more meaningful disclosure to allow investors to determine the nature of the assets held by and the operations of the respective guarantor and non-guarantor subsidiaries. Other wholly owned subsidiaries (Non-Guarantor Subsidiaries) that were not included among the Subsidiary Guarantors were not obligated with respect to the 2019 Notes and 2021 Notes. The properties held by the Non-Guarantor Subsidiaries are subject to mortgages. The following summarizes the Partnership’s condensed consolidating information as of September 30, 2014 and December 31, 2013 and for the three and nine months ended September 30, 2014, and 2013:
	CONDENSED CONSOLIDATING BALANCE SHEET
	As of September 30, 2014
	(in thousands)
	(unaudited)
		Issuers			Subsidiary			Non-			Eliminations			Consolidated
					Guarantors			Guarantor
								Subsidiaries
	Assets
	Net real estate	$	49		$	1,523,158		$	15,708		$	—		$	1,538,915
	Cash and cash equivalents		14,689			637			508			—			15,834
	Deferred finance costs, net		17,637			—			14			—			17,651
	Other		27,042			75,088			2,958			—			105,088
	Investment in and due from related parties, net		1,560,447			—			—			(1,560,447	)		—
	Total assets	$	1,619,864		$	1,598,883		$	19,188		$	(1,560,447	)	$	1,677,488
	Liabilities and partners’ capital
	Secured loan	$	—		$	—		$	13,478		$	—		$	13,478
	Unsecured loan		652,410			—			—			—			652,410
	Line of credit		175,000			—			—			—			175,000
	Accrued interest payable		10,857			—			46			—			10,903
	Dividends and distributions payable		21,078			—			—			—			21,078
	Accounts payable and accrued expenses		987			10,885			22			—			11,894
	Tenant security and escrow deposits		140			23,684			242			—			24,066
	Other liabilities		1,152			9,267			—			—			10,419
	Total liabilities		861,624			43,836			13,788			—			919,248
	Total partners’ capital		758,240			1,555,047			5,400			(1,560,447	)		758,240
	Total liabilities and partners’ capital	$	1,619,864		$	1,598,883		$	19,188		$	(1,560,447	)	$	1,677,488
	CONDENSED CONSOLIDATING BALANCE SHEET
	As of December 31, 2013
	(in thousands)
	(unaudited)
		Issuers			Subsidiary			Non-			Eliminations			Consolidated
					Guarantors			Guarantor
								Subsidiaries
	Assets
	Net real estate	$	55		$	1,148,057		$	15,376		$	—		$	1,163,488
	Cash and cash equivalents		50,709			(714	)		769			—			50,764
	Deferred finance costs, net		12,681			3,948			14			—			16,643
	Other		25,260			71,372			2,906			—			99,538
	Investment in and due from related parties, net		1,168,729			—			—			(1,168,729	)		—
	Total assets	$	1,257,434		$	1,222,663		$	19,065		$	(1,168,729	)	$	1,330,433
	Liabilities and partners’ capital
	Secured loan	$	—		$	—		$	13,654		$	—		$	13,654
	Unsecured loan		652,752			—			—			—			652,752
	Line of credit		—			20,000			—			—			20,000
	Accrued interest payable		14,750			487			47			—			15,284
	Dividends and distributions payable		17,694			—			—			—			17,694
	Accounts payable and accrued expenses		2,082			8,473			—			—			10,555
	Tenant security and escrow deposits		765			20,572			249			—			21,586
	Other liabilities		946			9,517			—			—			10,463
	Total liabilities		688,989			59,049			13,950			—			761,988
	Total partners’ capital		568,445			1,163,614			5,115			(1,168,729	)		568,445
	Total liabilities and partners’ capital	$	1,257,434		$	1,222,663		$	19,065		$	(1,168,729	)	$	1,330,433
	CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
	For the Three Months Ended September 30, 2014
	(in thousands)
	(unaudited)
		Issuers			Subsidiary			Non-			Eliminations			Consolidated
					Guarantors			Guarantor
								Subsidiaries
	Revenues
	Rental income	$	—		$	45,715		$	364		$	—		$	46,079
Interest on loans and financing lease		278			823			—			—			1,101
Interest and other income		8			183			—			—			191
Total revenues		286			46,721			364			—			47,371
Expenses
Interest expense incurred		12,237			—			139			—			12,376
Amortization of deferred financing costs		988			—			—			—			988
Depreciation and amortization		2			11,414			106			—			11,522
General and administrative		1,982			3,301			14			—			5,297
Transaction costs		52			1,168			—			—			1,220
Loss on impairment		—			1,479			—			—			1,479
Reserve for uncollectible loan receivables and other receivables		—			9			—			—			9
Loss on sale of assets, net		—			2,445			—			—			2,445
Loss on extinguishment of debt		—			—			—			—			—
Total expenses		15,261			19,816			259			—			35,336
Net (loss) income		(14,975	)		26,905			105			—			12,035
Equity in income (loss) of subsidiaries		27,010			—			—			(27,010	)		—
Net income (loss) allocable to units	$	12,035		$	26,905		$	105		$	(27,010	)	$	12,035
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Three Months Ended September 30, 2013
(in thousands)
(unaudited)
	Issuers			Subsidiary			Non-			Eliminations			Consolidated
				Guarantors			Guarantor
							Subsidiaries
Revenues
Rental income	$	—		$	31,005		$	688		$	—		$	31,693
Interest on loans and financing lease		262			869			—			—			1,131
Interest and other income		—			49			—			—			49
Total revenues		262			31,923			688			—			32,873
Expenses
Interest expense incurred		7,641			795			141			—			8,577
Amortization of deferred financing costs		369			441			—			—			810
Depreciation and amortization		2			8,130			170			—			8,302
General and administrative		1,393			2,458			16			—			3,867
Transaction costs		536			674			—			—			1,210
Reserve for uncollectible loan receivables and other receivables		—			27			—			—			27
Loss on sale of assets, net		—			—			13			—			13
Total expenses		9,941			12,525			340			—			22,806
Net (loss) income		(9,679	)		19,398			348			—			10,067
Equity in income (loss) of subsidiaries		19,746			—			—			(19,746	)		—
Net income (loss) allocable to units	$	10,067		$	19,398		$	348		$	(19,746	)	$	10,067
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Nine Months Ended September 30, 2014
(in thousands)
(unaudited)
	Issuers			Subsidiary			Non-			Eliminations			Consolidated
				Guarantors			Guarantor
							Subsidiaries
Revenues
Rental income	$	—		$	126,869		$	1,072		$	—		$	127,941
Interest on loans and financing lease		727			2,536			—			—			3,263
Interest and other income		482			750			—			—			1,232
Total revenues		1,209			130,155			1,072			—			132,436
Expenses
Interest expense incurred		34,903			1,167			419			—			36,489
Amortization of deferred financing costs		2,288			656			—			—			2,944
Depreciation and amortization		6			31,155			309			—			31,470
General and administrative		6,855			10,044			61			—			16,960
Transaction costs		134			3,678			1			—			3,813
Loss on impairment		—			2,341			—			—			2,341
Reserve for uncollectible loan receivables and other receivables		3,211			298			—			—			3,509
Loss on sale of assets, net		—			2,458			—			—			2,458
Loss on extinguishment of debt		—			501			—			—			501
Total expenses		47,397			52,298			790			—			100,485
Net (loss) income		(46,188	)		77,857			282			—			31,951
Equity in income (loss) of subsidiaries		78,139			—			—			(78,139	)		—
Net income (loss) allocable to units	$	31,951		$	77,857		$	282		$	(78,139	)	$	31,951
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Nine Months Ended September 30, 2013
(in thousands)
(unaudited)
	Issuers			Subsidiary			Non-			Eliminations			Consolidated
				Guarantors			Guarantor
							Subsidiaries
Revenues
Rental income	$	—		$	96,666		$	2,540		$	—		$	99,206
Interest on loans and financing lease		836			2,436			—			—			3,272
Interest and other income		5			123			—			—			128
Total revenues		841			99,225			2,540			—			102,606
Expenses
Interest expense incurred		22,932			6,200			467			—			29,599
Amortization of deferred financing costs		1,094			1,422			—			—			2,516
Depreciation and amortization		4			23,881			514			—			24,399
General and administrative		13,714			7,364			72			—			21,150
Transaction costs		718			1,173			15			—			1,906
Reserve for uncollectible loan receivables and other receivables		(10	)		77			(10	)		—			57
Loss (gain) on sale of assets, net		—			374			(400	)		—			(26	)
Loss on extinguishment of debt		—			10,974			—			—			10,974
Total expenses		38,452			51,465			658			—			90,575
Net (loss) income		(37,611	)		47,760			1,882			—			12,031
Equity in income (loss) of subsidiaries		49,642			—			—			(49,642	)		—
Net income (loss) allocable to units	$	12,031		$	47,760		$	1,882		$	(49,642	)	$	12,031
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Nine Months Ended September 30, 2014
(in thousands)
(unaudited)
	Issuers			Subsidiary			Non-			Eliminations			Consolidated
				Guarantors			Guarantor
							Subsidiaries
Net cash (used in) provided by operating activities	$	(358,512	)	$	428,124		$	476		$	—		$	70,088
Investing activities
Purchase of real estate		—			(368,870	)		—			—			(368,870	)
Proceeds from sales of real estate, net		—			1,337			—			—			1,337
Capital improvements		—			(9,673	)		(620	)		—			(10,293	)
Development projects		—			(30,316	)		—			—			(30,316	)
Loan receivables received from others		2,102			5,511			—			—			7,613
Loan receivables funded to others		(7,648	)		(4,762	)		—			—			(12,410	)
Net cash used in investing activities		(5,546	)		(406,773	)		(620	)		—			(412,939	)
Financing activities
Borrowings of debt		185,000			98,000			—			—			283,000
Repayment of debt		(10,000	)		(118,000	)		(117	)		—			(128,117	)
Payment of financing costs		(4,588	)		—			—			—			(4,588	)
Capital contributions		60			—			—			—			60
Public offering proceeds		221,720			—			—			—			221,720
Cost of raising capital		(10,551	)		—			—			—			(10,551	)
Units issued for settlement of vested stock and exercised unit options, net		3,053			—			—			—			3,053
Cash distributions to partners		(56,656	)		—			—			—			(56,646	)
Net cash provided by (used in) financing activities		328,038			(20,000	)		(117	)		—			307,921
Net (decrease) increase in cash and cash equivalents		(36,020	)		1,351			(261	)		—			(34,930	)
Cash and cash equivalents:
Beginning of period		50,709			(714	)		769			—			50,764
End of period	$	14,689		$	637		$	508		$	—		$	15,834
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Nine Months Ended September 30, 2013
(in thousands)
(unaudited)
	Issuers			Subsidiary			Non-			Eliminations			Consolidated
				Guarantors			Guarantor
							Subsidiaries
Net cash (used in) provided by operating activities	$	(220,414	)	$	259,381		$	(2,572	)	$	—		$	36,395
Investing activities
Purchase of real estate		—			(38,076	)		—			—			(38,076	)
Proceeds from sales of real estate, net		—			1,772			3,070			—			4,842
Capital improvements		(6	)		(9,865	)		(38	)		—			(9,909	)
Development projects		—			(14,380	)		—			—			(14,380	)
Loan receivables received from others		2,041			1,181			—			—			3,222
Loan receivables funded to others		(370	)		(2,387	)		—			—			(2,707	)
Net cash provided by (used in) investing activities		1,665			(61,705	)		3,032			—			(57,008	)
Financing activities
Borrowings of debt		—			160,000			—			—			160,000
Repayment of debt		—			(353,091	)		(112	)		—			(353,203	)
Payment of financing costs		—			(5,290	)		—			—			(5,290	)
Capital contributions		425			—			—			—			425
Initial public offering proceeds		303,600			—			—			—			303,600
Cost of raising capital		(25,380	)		—			—			—			(25,380	)
Cash distributions to partners		(65,183	)		—			—			—			(65,183	)
Net cash provided by (used in) financing activities		213,462			(198,381	)		(112	)		—			14,969
Net increase (decrease) in cash and cash equivalents		(5,287	)		(705	)		348			—			(5,644	)
Cash and cash equivalents:
Beginning of period		16,869			(1,861	)		526			—			17,876
End of period	$	11,582		$	(2,566	)	$	874		$	—		$	12,232

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2014
Basis of Presentation	'
	Basis of Presentation
	This report combines the Quarterly Reports on Form 10-Q for the quarter ended September 30, 2014 of AVIV and the Partnership. AVIV is a real estate investment trust (REIT) and the sole general partner of the Partnership. The Partnership’s capital consists of OP units. As the sole general partner of the Partnership, AVIV has exclusive control of the Partnership’s day-to-day management.
	The Company believes combining the Quarterly Reports on Form 10-Q of AVIV and the Partnership into this single report provides the following benefits:
		•		enhances investors’ understanding of AVIV and the Partnership by enabling investors to view the business as a whole in the same manner as management views and operates the business;
		•		eliminates duplicative disclosure and provides a more streamlined and readable presentation because a substantial portion of the disclosure in this report applies to both AVIV and the Partnership; and
		•		creates time and cost efficiencies through the preparation of one combined report instead of two separate reports.
	Management operates AVIV and the Partnership as one business. The management of AVIV consists of the same individuals as the management of the Partnership.
	The Company believes it is important for investors to understand the few differences between AVIV and the Partnership in the context of how AVIV and the Partnership operate as a consolidated company. AVIV is a REIT, whose only material asset is its ownership of OP units of the Partnership. As a result, AVIV does not conduct business itself, other than acting as the sole general partner of the Partnership, issuing public equity from time to time and guaranteeing unsecured debt of the Partnership. AVIV has not issued any indebtedness, but has guaranteed all of the unsecured debt of the Partnership. The Partnership indirectly holds all the real estate assets of the Company. Except for net proceeds from public equity issuances by AVIV, which are contributed to the Partnership in exchange for OP units, the Partnership generates all remaining capital required by the Company’s business. The sources of the remaining capital include the operations of the Partnership’s direct and indirect subsidiaries, its direct or indirect incurrence of indebtedness, and the issuance of OP units.
	As general partner with control of the Partnership, AVIV consolidates the Partnership for financial reporting purposes. The presentation of stockholders’ equity and partners’ capital are the main areas of difference between the consolidated financial statements of AVIV and those of the Partnership. AVIV’s stockholders’ equity consists of common stock, additional paid in capital and retained earnings (accumulated deficit). The Partnership’s capital consists of OP units that are owned by AVIV and other investors. The OP units held by the other investors in the Partnership are presented as part of partners’ capital in the Partnership’s consolidated financial statements and as “noncontrolling interests-operating partnership” in AVIV’s consolidated financial statements. There is no difference between the assets and liabilities or net income of AVIV and the Partnership as of and for the three and nine months ended September 30, 2014.
	The accompanying unaudited consolidated financial statements have been prepared by management in accordance with US generally accepted accounting principles (US GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. All significant intercompany accounts and transactions have been eliminated in the consolidated financial statements.
	The Company manages its business as a single business segment as defined in Accounting Standards Codification (ASC) 280, Segment Reporting. The Company has one reportable segment consisting of investments in healthcare properties, consisting primarily of SNFs, assisted living facilities (ALFs), and other healthcare properties located in the United States. All of the Company’s properties generate similar types of revenues and expenses related to tenant rent and reimbursements and operating expenses.
Quarterly Reporting	'
	Quarterly Reporting
	The accompanying unaudited consolidated financial statements and notes of the Company as of September 30, 2014 and for the three and nine months ended September 30, 2014 and 2013 have been prepared in accordance with US GAAP for interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared under US GAAP have been condensed or omitted pursuant to US GAAP quarterly reporting rules. In the opinion of management, all adjustments considered necessary for a fair presentation of the Company’s balance sheets, statements of operations, statement of changes in equity/partners’ capital, and statements of cash flows have been included and are of a normal and recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for the Company for the years ended December 31, 2013, 2012, and 2011. The consolidated statements of operations and cash flows for the periods ended September 30, 2014 and 2013 are not necessarily indicative of full year results.
	The balance sheets at December 31, 2013 have been derived from the audited financial statements at that date, but do not include all of the information and footnotes required by US GAAP for complete financial statements. For further information, including definitions of capitalized terms not defined herein, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission.
Estimates	'
	Estimates
	The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	Cash and cash equivalents consist of cash and highly liquid short-term investments with original maturities of three months or less. The Company maintains cash and cash equivalents in United States banking institutions that exceed amounts insured by the Federal Deposit Insurance Corporation. The Company believes the risk of loss from exceeding this insured level is minimal.
Real Estate Investments	'
	Real Estate Investments
	The Company periodically assesses the carrying value of real estate investments and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and circumstances exist that would suggest that assets might be impaired or that the useful lives should be modified. In the event impairment in value occurs and a portion of the carrying amount of the real estate investments will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the real estate investments and related intangibles to their estimated fair value. The estimated fair value of the Company’s rental properties is determined by using customary industry standard methods that include discounted cash flow and/or direct capitalization analysis (Level 3) or estimated cash proceeds received upon the anticipated disposition of the asset from market comparables (Level 2). As part of the impairment evaluation, the buildings in the following locations were impaired to reflect the estimated fair values (Level 2).
			For the Nine Months Ended September 30,
			2014		2013
			(in thousands)
	Willmar, MN		$	862	$	—
	Jasper, TX			1,479		—
			$	2,341	$	—
Purchase Accounting	'
	Purchase Accounting
	The Company allocates the purchase price of facilities between net tangible and identified intangible assets acquired and liabilities assumed as a result of the Company purchasing the business and subsequently leasing the business to unrelated third party operators. The Company makes estimates of the fair value of the tangible and intangible assets and acquired liabilities using information obtained from multiple sources as a result of pre-acquisition due diligence, marketing, leasing activities of the Company’s operator base, industry surveys of critical valuation metrics such as capitalization rates, discount rates and leasing rates and appraisals (Level 3). The Company allocates the purchase price of facilities to net tangible and identified intangible assets and liabilities acquired based on their fair values in accordance with the provisions of ASC 805, Business Combinations (ASC 805). The determination of fair value involves the use of significant judgment and estimation.
	The Company determines fair values as follows:
		•		Real estate investments are valued using discounted cash flow projections that assume certain future revenue and costs and consider capitalization and discount rates using current market conditions.
		•		The Company allocates the purchase price of facilities to net tangible and identified intangible assets acquired and liabilities assumed based on their fair values.
		•		Other assets acquired and other liabilities assumed are valued at stated amounts, which approximate fair value.
		•		Assumed debt balances are valued at fair value, with the computed discount/premium amortized over the remaining term of the obligation.
	The Company determines the value of land based on third party appraisals. The fair value of in-place leases, if any, reflects: (i) above and below-market leases, if any, determined by discounting the difference between the estimated current market rent and the in-place rentals, the resulting intangible asset or liability of which is amortized to rental revenue over the remaining life of the associated lease plus any fixed rate renewal periods if applicable; (ii) the estimated value of the cost to obtain operators, including operator allowances, operator improvements, and leasing commissions, which is amortized over the remaining life of the associated lease; and (iii) an estimated value of the absorption period to reflect the value of the rents and recovery costs foregone during a reasonable lease-up period as if the acquired space was vacant, which is amortized over the remaining life of the associated lease. The Company also estimates the value of operator or other customer relationships acquired by considering the nature and extent of existing business relationships with the operator, growth prospects for developing new business with such operator, such operator’s credit quality, expectations of lease renewals with such operator, and the potential for significant, additional future leasing arrangements with such operator. The Company amortizes such value, if any, over the expected term of the associated arrangements or leases, which would include the remaining lives of the related leases. The amortization is included in the consolidated statements of operations in rental income for above or below market leases or depreciation and amortization expense for in-place lease assets. Generally, the Company’s purchase price allocation of the purchased business and subsequent leasing of the business to unrelated third party operators does not include an allocation to any intangible assets or intangible liabilities, as they are either immaterial or do not exist.
Revenue Recognition	'
	Revenue Recognition
	Rental income is recognized on a straight-line basis over the term of the lease when collectability is reasonably assured. Differences between rental income earned and amounts due under the lease are charged or credited, as applicable, to straight-line rent receivable, net. Income recognized from this policy is titled straight-line rental income. Additional rents from expense reimbursements for insurance, real estate taxes, and certain other expenses are recognized in the period in which the related expenses are incurred and the net impact is reflected in rental income on the consolidated statements of operations.
	Below is a summary of the components of rental income for the three and nine months ended September 30, 2014 and 2013 (in thousands):
			Three Months Ended					Nine Months Ended
			September 30,					September 30,
			2014		2013			2014		2013
	Cash rental income		$	44,220	$	32,555		$	123,982	$	95,111
	Straight-line rental income (expense), net			1,727		(1,227	)		3,420		2,998
	Rental income from intangible amortization, net			132		365			539		1,097
	Total rental income		$	46,079	$	31,693		$	127,941	$	99,206
	The Company’s reserve for uncollectible operator receivables is included as a component of reserve for uncollectible loans and other receivables in the consolidated statements of operations.
Lease Accounting	'
	Lease Accounting
	The Company, as lessor, makes a determination with respect to each of its leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. Payments received under operating leases are accounted for in the statements of operations as rental income for actual rent collected plus or minus a straight-line adjustment for estimated minimum lease escalators. Assets subject to operating leases are reported as real estate investments in the consolidated balance sheets. For facilities leased as direct financing arrangements, an asset equal to the Company’s net initial investment is established on the balance sheet titled assets under direct financing leases. Payments received under the financing lease are bifurcated between interest income and principal amortization to achieve a consistent yield over the stated lease term using the interest method. Principal amortization (accretion) is reflected as an adjustment to the asset subject to a financing lease.
	All of the Company’s leases contain fixed or formula-based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.
Deferred Finance Costs	'
	Deferred Finance Costs
	Deferred finance costs are being amortized using the straight-line method, which approximates the interest method, over the term of the respective underlying debt agreement.
Loan Receivables	'
	Loan Receivables
	Loan receivables consist of mortgage loans, capital improvement loans and working capital loans to operators. Mortgage loans represent the financing provided by the Company to operators or owners that are secured by mortgages on real property. Capital improvement loans represent the financing provided by the Company to perform certain capital improvements and/or to acquire furniture, fixtures, and equipment while the operator is operating the facility. Working capital loans to operators represent financing provided by the Company to operators for working capital needs that are secured with non-mortgage collateral or that are unsecured. Loan receivables are carried at their principal amount outstanding. Management periodically evaluates outstanding loans and notes receivable for collectability on a loan-by-loan basis. When management identifies potential loan impairment indicators, such as nonpayment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator, or other circumstances that may impair full execution of the loan documents, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan, the loan is written down to the present value of the expected future cash flows. Loan impairment is monitored via a quantitative and qualitative analysis including credit quality indicators and it is reasonably possible that a change in estimate could occur in the near term. As of September 30, 2014 and December 31, 2013, loan receivable reserves amounted to approximately $3.2 million and $0, respectively. No other circumstances exist that would suggest that additional reserves are necessary at the balance sheet dates other than as disclosed in Footnote 4, Loan Receivables.
Stock-Based Compensation	'
	Stock-Based Compensation
	The Company follows ASC 718, Stock Compensation (ASC 718) in accounting for its stock-based payments. This guidance requires measurement of the cost of employee services received in exchange for stock compensation based on the grant-date fair value of the employee stock awards. This cost is recognized as compensation expense ratably over the employee’s requisite service period. Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized when incurred. Additionally, the Company must make estimates regarding employee forfeitures in determining compensation expense. Subsequent changes in actual experience are monitored and estimates are updated as information is available. The non-cash stock-based compensation expense incurred by the Company through September 30, 2014 is summarized in Footnote 12, Equity Compensation Plan.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	ASC 820, Fair Value Measurements and Disclosures (ASC 820), establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels are defined as follows:
		•		Level 1—Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets;
		•		Level 2—Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument; and
		•		Level 3—Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
	Cash and cash equivalents are reflected in the accompanying consolidated balance sheets at amounts considered by management to reasonably approximate fair value. Management estimates the fair value of its long-term debt using a discounted cash flow analysis based upon the Company’s current borrowing rate for debt with similar maturities and collateral securing the indebtedness. The Company had outstanding secured loans, unsecured notes payable, and a line of credit with a carrying value of approximately $840.9 million and $686.4 million as of September 30, 2014 and December 31, 2013, respectively. The fair values of debt as of September 30, 2014 and December 31, 2013 were $863.6 million and $705.8 million, respectively, based upon interest rates available to the Company on similar borrowings (Level 3). Management estimates the fair value of its loan receivables using a discounted cash flow analysis based upon the Company’s current interest rates for loan receivables with similar maturities and collateral securing the indebtedness. The Company had outstanding loan receivables with a carrying value of approximately $43.3 million and $41.7 million as of September 30, 2014 and December 31, 2013, respectively. The fair values of loan receivables as of September 30, 2014 and December 31, 2013 approximate their carrying value based upon interest rates available to the Company on similar borrowings.
Income Taxes	'
	Income Taxes
	For federal income tax purposes, the Company elected, with the filing of its initial Form 1120 REIT, U.S. Income Tax Return for U.S. Real Estate Investment Trusts, to be taxed as a REIT effective as of the Company’s taxable year ending December 31, 2010. To qualify as a REIT, the Company must meet certain organizational, income, asset and distribution tests. The Company currently is in compliance with these requirements and intends to maintain REIT status. If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to federal income taxes at regular corporate rates (including any applicable alternative minimum tax) and may not elect REIT status for four subsequent years. However, the Company may still be subject to federal excise tax. In addition, the Company may be subject to certain state and local income and franchise taxes. Historically, the Company and its predecessor have generally only incurred certain state and local income and franchise taxes, but these amounts were immaterial in each of the periods presented. Prior to September 2010, the Partnership was taxed as a limited partnership, and the consolidated operating results were included in the income tax returns of the individual partners. No uncertain income tax positions exist as of September 30, 2014 or December 31, 2013.
Noncontrolling Interests-Operating Partnership / Partnership Units	'
	Noncontrolling Interests—Operating Partnership / Partnership Units
	Noncontrolling interests—operating partnership, as presented on AVIV’s consolidated balance sheets, represent OP units held by individuals and entities other than AVIV.
	Noncontrolling interests—operating partnership, which can be settled in cash or, at the REIT’s election, by issuance of unregistered shares of AVIV’s common stock, are reported in the equity section of the consolidated balance sheets of AVIV. They are adjusted for income, losses and distributions allocated to OP units not held by AVIV. Adjustments to noncontrolling interests—operating partnership are recorded to reflect increases or decreases in the ownership of the Partnership by holders of OP units as a result of the redemptions of OP units for cash or, at the election of AVIV, in exchange for shares of AVIV’s common stock.
	Prior to the IPO, the capital structure of the Company’s operating partnership consisted of six classes of partnership units, each of which had different capital accounts and each of which was entitled to different distributions. In connection with the IPO, each class of units of the Partnership was converted into an aggregate of 11,938,420 OP units held by investors other than AVIV in the Partnership. As of September 30, 2014, there were 11,416,426 OP units outstanding.
Earnings Per Share	'
	Earnings Per Share of the REIT
	Basic earnings per share is calculated by dividing the net income allocable to common shares for the period by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated by dividing the net income allocable to common shares for the period by the weighted average number of common and dilutive securities outstanding during the period.
Risks and Uncertainties	'
	Risks and Uncertainties
	The Company is subject to certain risks and uncertainties affecting the healthcare industry as a result of healthcare legislation and continuing regulation by federal, state, and local governments. Additionally, the Company is subject to risks and uncertainties as a result of changes affecting operators of nursing home facilities due to the actions of governmental agencies and insurers to limit the growth in cost of healthcare services.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	In April 2014, the FASB issued ASU No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (ASU No. 2014-08). ASU No. 2014-08 changes the definition of a discontinued operation to include only those disposals of components of an entity that represent a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. ASU No. 2014-08 is effective prospectively for fiscal years beginning after December 15, 2014 and is available for early adoption as of January 1, 2014. The Company adopted the provisions of ASU No. 2014-08 as of January 1, 2014 and incorporated the provisions of this update to its condensed consolidated financial statements upon adoption. The adoption of ASU No. 2014-08 did not have a material impact on the Company’s financial condition or results of operations.
	In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which creates a new topic, Accounting Standards Codification Topic 606 (Topic 606). The standard is principle-based and provides a five-step model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This standard is effective for interim or annual periods beginning after December 15, 2016 and allows for either full retrospective or modified retrospective adoption. Early adoption of this standard is not allowed. The Company is currently evaluating the impact the adoption of Topic 606 will have on its consolidated financial statements.
	In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements - Going Concern.” This update provide guidance about management’s responsibilities to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures in certain circumstances. An entity’s management, in connection with the preparation of financial statements, to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. Management’s evaluation should be based on relevant conditions and events that are known or reasonably knowable at the date the financial statements are issued. When management identifies conditions or events that raise substantial doubt about an entity’s ability to continue as a going concern, the entity should disclose information that enables users of the financial statements to understand all of the following: (1) principal conditions or events that raised substantial doubt about the entity’s ability to continue as a going concern (before consideration of management’s plans); (2) management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations; and (3) management’s plans that alleviated substantial doubt about the entity’s ability to continue as a going concern or management’s plans that are intended to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. ASU No. 2014-15 is effective for interim and annual reporting periods after December 15, 2016 and early application is permitted. The Company is currently assessing this guidance for future implementation.
Reclassifications	'
	Reclassifications
	Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the Company’s consolidated financial position or results of operations.
Aviv Healthcare Properties Limited Partnership	'
Earnings Per Share	'
	Earnings Per Unit of the Partnership
	Basic earnings per unit is calculated by dividing the net income allocable to units for the period by the weighted average number of OP units outstanding during the period. Diluted earnings per unit is calculated by dividing the net income allocable to OP units for the period by the weighted average number of units and dilutive securities outstanding during the period.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2014
Buildings Impaired to Reflect Estimated Fair Values (Level 2)	'
	As part of the impairment evaluation, the buildings in the following locations were impaired to reflect the estimated fair values (Level 2).
		For the Nine Months Ended September 30,
		2014		2013
		(in thousands)
	Willmar, MN	$	862	$	—
	Jasper, TX		1,479		—
		$	2,341	$	—
Components of Rental Income	'
	Below is a summary of the components of rental income for the three and nine months ended September 30, 2014 and 2013 (in thousands):
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2014		2013			2014		2013
	Cash rental income	$	44,220	$	32,555		$	123,982	$	95,111
	Straight-line rental income (expense), net		1,727		(1,227	)		3,420		2,998
	Rental income from intangible amortization, net		132		365			539		1,097
	Total rental income	$	46,079	$	31,693		$	127,941	$	99,206

Real_Estate_Assets_Tables

Real Estate Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Rental Property Activity	'
	The Company had the following acquisitions during the nine months ended September 30, 2014 as described below:
	Month Acquired	Property Type		Location	Purchase Price
					(in thousands)
	January	SNF/ALF/ILF		MN	$	40,000
	January	SNF		TX		15,920
	March	SNF		IA		13,500
	March	SNF		KY		35,000
	April	SNF		FL		6,000
	April	SNF		TX		53,700
	May	SNF		TX		3,600
	May	SNF		CA		13,350
	June	SNF		KY		6,000
	July	SNF		MO		16,200
	July	ALF		MA		32,000
	July	SNF/ALF		MA		50,000
	September	SNF/ALF		WA/ID		83,600
						368,870
	February	Land Held for Development		TX		2,110
	July	Land Held for Development		MA		12,288
					$	383,268
Effect on Revenues and Net Income	'
	The following table illustrates the effect on total revenues and net income as if the Company had consummated the acquisitions as of January 1, 2013 (in thousands, unaudited):
		For the Three Months Ended					For the Nine Months Ended
		September 30,					September 30,
		2014			2013		2014		2013
	Total revenues	$	48,795		$	41,831	$	145,811	$	129,480
	Net income		13,874			16,442		43,838		31,173
Net Purchase Price Paid	'
	In accordance with ASC 805, the Company allocated the approximate net purchase price paid for these properties acquired in 2014 as follows (in thousands):
	Land	$	33,390
	Buildings and improvements		310,390
	Furniture, fixtures and equipment		25,090
	Construction in progress and land held for development		14,398
	Borrowings and available cash	$	383,268
Construction in Progress	'
	The following summarizes the Company’s construction in progress and land held for development during the nine months ended September 30, 2014 (in thousands):
		September 30, 2014
	Beginning balance, January 1	$	23,292
	Additions		31,170
	Placed in service		(20,041	)
		$	34,421

Loan_Receivables_Tables

Loan Receivables (Tables)	9 Months Ended
	Sep. 30, 2014
Loan Receivables, net	'
	The following summarizes the Company’s loan receivables, net activity during the nine months ended September 30, 2014 (in thousands):
		September 30, 2014
		Mortgage			Capital			Working			Total
		Loans			Improvement			Capital			Loans
					Loans			Loans
	Beginning balance, January 1, 2014	$	28,316		$	4,580		$	8,790		$	41,686
	New loans issued		4,762			—			7,648			12,410
	Reserve for uncollectible loans		—			—			(3,211	)		(3,211	)
	Loan amortization and repayments		(5,394	)		(760	)		(1,459	)		(7,613	)
		$	27,684		$	3,820		$	11,768		$	43,272
Interest Income on Loans and Financing Leases	'
	The following summarizes the Company’s interest income on loans and financing leases for the three and nine months ended September 30, 2014 and 2013 (in thousands):
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
	Mortgage loans	$	456		$	472		$	1,364		$	1,208
	Capital improvement loans		66			117			267			417
	Working capital loans		211			177			529			556
	Direct financing lease		368			365			1,103			1,091
	Total interest on loans and financing lease	$	1,101		$	1,131		$	3,263		$	3,272

Deferred_Finance_Costs_Tables

Deferred Finance Costs (Tables)	9 Months Ended
	Sep. 30, 2014
Deferred Finance Costs	'
	The following summarizes the Company’s deferred finance costs at September 30, 2014 and December 31, 2013 (in thousands):
		September 30,			December 31,
		2014			2013
	Gross amount	$	25,531		$	21,881
	Accumulated amortization		(7,880	)		(5,238	)
	Net	$	17,651		$	16,643

Intangible_Assets_and_Liabilit1

Intangible Assets and Liabilities (Tables)	9 Months Ended
	Sep. 30, 2014
Intangible Assets and Liabilities Classified as Part of Other Assets or Other Liabilities	'
	The following summarizes the Company’s intangible assets and liabilities classified as part of other assets or other liabilities at September 30, 2014 and December 31, 2013, respectively (in thousands):
		Assets
		September 30, 2014							December 31, 2013
		Gross Amount		Accumulated			Net		Gross Amount		Accumulated			Net
				Amortization							Amortization
	Above market leases	$	5,512	$	(2,830	)	$	2,682	$	6,437	$	(3,452	)	$	2,985
	In-place lease assets		652		(179	)		473		652		(130	)		522
	Operator relationship		212		(47	)		165		212		(34	)		178
		$	6,376	$	(3,056	)	$	3,320	$	7,301	$	(3,616	)	$	3,685
		Liabilities
		30-Sep-14							31-Dec-13
		Gross Amount		Accumulated			Net		Gross Amount		Accumulated			Net
				Amortization							Amortization
	Below market leases	$	12,933	$	(6,212	)	$	6,721	$	17,623	$	(10,059	)	$	7,564

Debt_Tables

Debt (Tables)	9 Months Ended
	Sep. 30, 2014
Components of Secured Loans, Unsecured Notes Payable and Line of Credit	'
	The Company’s secured loans, unsecured notes payable and line of credit consisted of the following (in thousands):
		September 30,		December 31,
		2014		2013
	HUD loan (interest rate of 5.00% on September 30, 2014 and December 31, 2013), inclusive of a $2.4 million and $2.4 million premium balance at September 30, 2014 and December 31, 2013, respectively	$	13,478	$	13,654
	2019 Notes (interest rate of 7.75% on September 30, 2014 and December 31, 2013), inclusive of $2.4 million and $2.8 million net premium balance, respectively		402,410		402,752
	2021 Notes (interest rate of 6.00% on September 30, 2014 and December 31, 2013)		250,000		250,000
	Credit Facility (interest rate of 1.85% on September 30, 2014)		175,000		—
	Revolving Credit Facility (interest rate of 2.52% on December 31, 2013)		—		20,000
	Total	$	840,888	$	686,406

Stockholders_Equity_of_the_REI1

Stockholders' Equity of the REIT and Partners' Capital of the Partnership (Tables)	9 Months Ended
	Sep. 30, 2014
Summary of Distributions Accrued	'
	Distributions accrued are summarized as follows for the three months ended September 30, (in thousands):
		Class A				Class B			Class C		Class D		Class F		OP Units		REIT Shares
	2014	$	—			$	—		$	—	$	—	$	—	$	4,110	$	17,009
	2013	$	—			$	—		$	—	$	—	$	—	$	4,298	$	13,435
	Distributions accrued are summarized as follows for the nine months ended September 30, (in thousands):
		Class A				Class B			Class C		Class D		Class F		OP Units		REIT Shares
	2014	$	—			$	—		$	—	$	—	$	—	$	12,374	$	47,666
	2013	$	2,797			$	97		$	146	$	—	$	554	$	8,882	$	34,286
Summary of Weighted-Average Units Outstanding	'
	The weighted-average units outstanding for each class of units are summarized as follows for the three months ended September 30:
		Class A				Class B			Class C		Class D		Class F		OP Units		REIT Shares
	2014		—				—			—		—		—		11,419,777		47,213,612
	2013		—				—			—		—		—		11,938,420		37,271,714
	The weighted-average units outstanding for each class of units are summarized as follows for the nine months ended September 30:
		Class A				Class B			Class C		Class D		Class F		OP Units		REIT Shares
	2014		—				—			—		—		—		11,478,543		43,576,705
	2013		4,193,031				1,408,305			—		2,506		835,958		8,221,330		32,408,843
Summary of Dividends Declared and Paid	'
	For the nine months ended September 30, 2014, AVIV declared the following cash dividends on its common stock, and the Partnership declared equivalent distributions on its OP units:
	Declaration Date	Record		Amount Per				Dividend Payment
		Date		Share				Date
	March 18, 2014	March 31, 2014		$	0.36			April 11, 2014
	May 27, 2014	27-Jun-14		$	0.36			July 11, 2014
	29-Jul-14	September 26, 2014		$	0.36			October 10, 2014
	Total			$	1.08

Equity_Compensation_Plan_Table

Equity Compensation Plan (Tables)	9 Months Ended
	Sep. 30, 2014
Number of Unvested Shares of Restricted Stock and Weighted Average Fair Value of Shares at Date of Grant	'
	The following table sets forth the number of unvested shares of restricted stock and the weighted average fair value of these shares at the date of grant:
			Nine Months Ended
			September 30, 2014					September 30, 2013
			Shares of			Weighted Average		Shares of		Weighted Average
			Restricted Stock			Fair Value of		Restricted Stock		Fair Value of
						Date of Grant				Date of Grant
	Unvested balance at January 1			256,092		$	29.83		—	$	—
	Granted			172,915		$	26.55		182,092	$	33.1
	Vested (1)			(40,055	)	$	23.08		—	$	—
	Forfeited			(26,724	)	$	30.53		—	$	—
	Unvested balance at September 30			362,228		$	28.96		182,092	$	33.1
	-1	Includes 7,944 shares which were used to settle minimum employee withholding tax obligations for one employee of approximately $0.2 million in 2014. A net of 32,111 shares of common stock were delivered in the nine months ended September 30, 2014.
Time Based Option Awards Activity	'
	The following table represents the time- and performance-based option awards activity for the nine months ended September 30, 2014 and 2013:
			Nine Months Ended
			September 30,			September 30,
			2014			2013
	Outstanding at January 1			5,870,138			1,956,713
	Exercised			(174,467	)		—
	Awards vested at IPO			—			3,913,425
	Outstanding at September 30			5,695,671			5,870,138
	Options exercisable at end of period			5,695,671			—
	Weighted average fair value of options granted		$	2.2		$	2.2
Time Based Option Awards Outstanding	'
	The following table represents the time- and performance-based option awards outstanding cumulatively life-to-date for the nine months ended September 30, 2014 and 2013 as well as other MIP data:
			2014		2013
	Range of exercise prices		$16.56-$18.87		$16.56 - $18.87
	Outstanding		5,695,671		5,870,138
	Remaining contractual life (years)		6.52		7.55
	Weighted average exercise price		$17.44		$17.47

Earnings_Per_Common_Share_of_t1

Earnings Per Common Share of the REIT (Tables)	9 Months Ended
	Sep. 30, 2014
Amounts Used in Computing Basic and Diluted Earnings per Common Share/ Unit	'
	The following table shows the amounts used in computing the basic and diluted earnings per common share (in thousands except for share and per share amounts).
		For the Three Months Ended						For the Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
	Numerator for earnings per common share—basic:
	Net income	$	12,035		$	10,067		$	31,951		$	12,031
	Net income allocable to noncontrolling interests		(2,344	)		(2,446	)		(6,662	)		(3,236	)
	Numerator for earnings per common share—basic	$	9,691		$	7,621		$	25,289		$	8,795
	Numerator for earnings per common share—diluted:
	Numerator for earnings per common share—basic	$	9,691		$	7,621		$	25,289		$	8,795
	Net income allocable to noncontrolling interests—OP units		2,344			2,446			6,662			2,228
	Numerator for earnings per common share—diluted	$	12,035		$	10,067		$	31,951		$	11,023
	Denominator for earnings per common share—basic and diluted:
	Denominator for earnings per common share—basic		47,213,612			37,271,714			43,576,705			32,408,843
	Effect of dilutive securities:
	Noncontrolling interests—OP units		11,419,777			11,938,420			11,478,543			8,221,330
	Stock options		2,155,075			1,599,302			1,953,632			1,454,735
	Restricted stock units		179,403			29,093			118,904			16,169
	Denominator for earnings per common share—diluted		60,967,867			50,838,529			57,127,784			42,101,077
	Basic earnings per common share
	Net income allocable to common stockholders	$	0.21		$	0.2		$	0.58		$	0.27
	Diluted earnings per common share
	Net income allocable to common stockholders	$	0.2		$	0.2		$	0.56		$	0.26
Aviv Healthcare Properties Limited Partnership	'
Amounts Used in Computing Basic and Diluted Earnings per Common Share/ Unit	'
	The following table shows the amounts used in computing the basic and diluted earnings per unit (in thousands except for unit and per unit amounts).
		For the Three Months Ended						For the Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
	Numerator for earnings per unit—basic:
	Net income	$	12,035		$	10,067		$	31,951		$	12,031
	Net income allocable to limited partners		—			—			—			(1,008	)
	Numerator for earnings per unit—basic:	$	12,035		$	10,067		$	31,951		$	11,023
	Numerator for earnings per unit— diluted:
	Numerator for earnings per unit—diluted	$	12,035		$	10,067		$	31,951		$	11,023
	Denominator for earnings per unit— basic and diluted:
	Denominator for basic earnings per unit— basic		58,633,389			49,210,134			55,055,248			40,630,173
	Effective dilutive securities:
	Stock options		2,155,075			1,599,302			1,953,632			1,454,735
	Restricted stock units		179,403			29,093			118,904			16,169
	Denominator for earnings per unit—diluted		60,967,867			50,838,529			57,127,784			42,101,077
	Basic earnings per unit:
	Net income allocable to units	$	0.21		$	0.2		$	0.58		$	0.27
	Diluted earnings per unit:
	Net income allocable to units	$	0.2		$	0.2		$	0.56		$	0.26

Condensed_Consolidating_Inform1

Condensed Consolidating Information (Tables)	9 Months Ended
	Sep. 30, 2014
Condensed Consolidating Information	'
	The following summarizes the Partnership’s condensed consolidating information as of September 30, 2014 and December 31, 2013 and for the three and nine months ended September 30, 2014, and 2013:
	CONDENSED CONSOLIDATING BALANCE SHEET
	As of September 30, 2014
	(in thousands)
	(unaudited)
		Issuers			Subsidiary			Non-			Eliminations			Consolidated
					Guarantors			Guarantor
								Subsidiaries
	Assets
	Net real estate	$	49		$	1,523,158		$	15,708		$	—		$	1,538,915
	Cash and cash equivalents		14,689			637			508			—			15,834
	Deferred finance costs, net		17,637			—			14			—			17,651
	Other		27,042			75,088			2,958			—			105,088
	Investment in and due from related parties, net		1,560,447			—			—			(1,560,447	)		—
	Total assets	$	1,619,864		$	1,598,883		$	19,188		$	(1,560,447	)	$	1,677,488
	Liabilities and partners’ capital
	Secured loan	$	—		$	—		$	13,478		$	—		$	13,478
	Unsecured loan		652,410			—			—			—			652,410
	Line of credit		175,000			—			—			—			175,000
	Accrued interest payable		10,857			—			46			—			10,903
	Dividends and distributions payable		21,078			—			—			—			21,078
	Accounts payable and accrued expenses		987			10,885			22			—			11,894
	Tenant security and escrow deposits		140			23,684			242			—			24,066
	Other liabilities		1,152			9,267			—			—			10,419
	Total liabilities		861,624			43,836			13,788			—			919,248
	Total partners’ capital		758,240			1,555,047			5,400			(1,560,447	)		758,240
	Total liabilities and partners’ capital	$	1,619,864		$	1,598,883		$	19,188		$	(1,560,447	)	$	1,677,488
	CONDENSED CONSOLIDATING BALANCE SHEET
	As of December 31, 2013
	(in thousands)
	(unaudited)
		Issuers			Subsidiary			Non-			Eliminations			Consolidated
					Guarantors			Guarantor
								Subsidiaries
	Assets
	Net real estate	$	55		$	1,148,057		$	15,376		$	—		$	1,163,488
	Cash and cash equivalents		50,709			(714	)		769			—			50,764
	Deferred finance costs, net		12,681			3,948			14			—			16,643
	Other		25,260			71,372			2,906			—			99,538
	Investment in and due from related parties, net		1,168,729			—			—			(1,168,729	)		—
	Total assets	$	1,257,434		$	1,222,663		$	19,065		$	(1,168,729	)	$	1,330,433
	Liabilities and partners’ capital
	Secured loan	$	—		$	—		$	13,654		$	—		$	13,654
	Unsecured loan		652,752			—			—			—			652,752
	Line of credit		—			20,000			—			—			20,000
	Accrued interest payable		14,750			487			47			—			15,284
	Dividends and distributions payable		17,694			—			—			—			17,694
	Accounts payable and accrued expenses		2,082			8,473			—			—			10,555
	Tenant security and escrow deposits		765			20,572			249			—			21,586
	Other liabilities		946			9,517			—			—			10,463
	Total liabilities		688,989			59,049			13,950			—			761,988
	Total partners’ capital		568,445			1,163,614			5,115			(1,168,729	)		568,445
	Total liabilities and partners’ capital	$	1,257,434		$	1,222,663		$	19,065		$	(1,168,729	)	$	1,330,433
	CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
	For the Three Months Ended September 30, 2014
	(in thousands)
	(unaudited)
		Issuers			Subsidiary			Non-			Eliminations			Consolidated
					Guarantors			Guarantor
								Subsidiaries
	Revenues
	Rental income	$	—		$	45,715		$	364		$	—		$	46,079
	Interest on loans and financing lease		278			823			—			—			1,101
Interest and other income		8			183			—			—			191
Total revenues		286			46,721			364			—			47,371
Expenses
Interest expense incurred		12,237			—			139			—			12,376
Amortization of deferred financing costs		988			—			—			—			988
Depreciation and amortization		2			11,414			106			—			11,522
General and administrative		1,982			3,301			14			—			5,297
Transaction costs		52			1,168			—			—			1,220
Loss on impairment		—			1,479			—			—			1,479
Reserve for uncollectible loan receivables and other receivables		—			9			—			—			9
Loss on sale of assets, net		—			2,445			—			—			2,445
Loss on extinguishment of debt		—			—			—			—			—
Total expenses		15,261			19,816			259			—			35,336
Net (loss) income		(14,975	)		26,905			105			—			12,035
Equity in income (loss) of subsidiaries		27,010			—			—			(27,010	)		—
Net income (loss) allocable to units	$	12,035		$	26,905		$	105		$	(27,010	)	$	12,035
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Three Months Ended September 30, 2013
(in thousands)
(unaudited)
	Issuers			Subsidiary			Non-			Eliminations			Consolidated
				Guarantors			Guarantor
							Subsidiaries
Revenues
Rental income	$	—		$	31,005		$	688		$	—		$	31,693
Interest on loans and financing lease		262			869			—			—			1,131
Interest and other income		—			49			—			—			49
Total revenues		262			31,923			688			—			32,873
Expenses
Interest expense incurred		7,641			795			141			—			8,577
Amortization of deferred financing costs		369			441			—			—			810
Depreciation and amortization		2			8,130			170			—			8,302
General and administrative		1,393			2,458			16			—			3,867
Transaction costs		536			674			—			—			1,210
Reserve for uncollectible loan receivables and other receivables		—			27			—			—			27
Loss on sale of assets, net		—			—			13			—			13
Total expenses		9,941			12,525			340			—			22,806
Net (loss) income		(9,679	)		19,398			348			—			10,067
Equity in income (loss) of subsidiaries		19,746			—			—			(19,746	)		—
Net income (loss) allocable to units	$	10,067		$	19,398		$	348		$	(19,746	)	$	10,067
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Nine Months Ended September 30, 2014
(in thousands)
(unaudited)
	Issuers			Subsidiary			Non-			Eliminations			Consolidated
				Guarantors			Guarantor
							Subsidiaries
Revenues
Rental income	$	—		$	126,869		$	1,072		$	—		$	127,941
Interest on loans and financing lease		727			2,536			—			—			3,263
Interest and other income		482			750			—			—			1,232
Total revenues		1,209			130,155			1,072			—			132,436
Expenses
Interest expense incurred		34,903			1,167			419			—			36,489
Amortization of deferred financing costs		2,288			656			—			—			2,944
Depreciation and amortization		6			31,155			309			—			31,470
General and administrative		6,855			10,044			61			—			16,960
Transaction costs		134			3,678			1			—			3,813
Loss on impairment		—			2,341			—			—			2,341
Reserve for uncollectible loan receivables and other receivables		3,211			298			—			—			3,509
Loss on sale of assets, net		—			2,458			—			—			2,458
Loss on extinguishment of debt		—			501			—			—			501
Total expenses		47,397			52,298			790			—			100,485
Net (loss) income		(46,188	)		77,857			282			—			31,951
Equity in income (loss) of subsidiaries		78,139			—			—			(78,139	)		—
Net income (loss) allocable to units	$	31,951		$	77,857		$	282		$	(78,139	)	$	31,951
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Nine Months Ended September 30, 2013
(in thousands)
(unaudited)
	Issuers			Subsidiary			Non-			Eliminations			Consolidated
				Guarantors			Guarantor
							Subsidiaries
Revenues
Rental income	$	—		$	96,666		$	2,540		$	—		$	99,206
Interest on loans and financing lease		836			2,436			—			—			3,272
Interest and other income		5			123			—			—			128
Total revenues		841			99,225			2,540			—			102,606
Expenses
Interest expense incurred		22,932			6,200			467			—			29,599
Amortization of deferred financing costs		1,094			1,422			—			—			2,516
Depreciation and amortization		4			23,881			514			—			24,399
General and administrative		13,714			7,364			72			—			21,150
Transaction costs		718			1,173			15			—			1,906
Reserve for uncollectible loan receivables and other receivables		(10	)		77			(10	)		—			57
Loss (gain) on sale of assets, net		—			374			(400	)		—			(26	)
Loss on extinguishment of debt		—			10,974			—			—			10,974
Total expenses		38,452			51,465			658			—			90,575
Net (loss) income		(37,611	)		47,760			1,882			—			12,031
Equity in income (loss) of subsidiaries		49,642			—			—			(49,642	)		—
Net income (loss) allocable to units	$	12,031		$	47,760		$	1,882		$	(49,642	)	$	12,031
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Nine Months Ended September 30, 2014
(in thousands)
(unaudited)
	Issuers			Subsidiary			Non-			Eliminations			Consolidated
				Guarantors			Guarantor
							Subsidiaries
Net cash (used in) provided by operating activities	$	(358,512	)	$	428,124		$	476		$	—		$	70,088
Investing activities
Purchase of real estate		—			(368,870	)		—			—			(368,870	)
Proceeds from sales of real estate, net		—			1,337			—			—			1,337
Capital improvements		—			(9,673	)		(620	)		—			(10,293	)
Development projects		—			(30,316	)		—			—			(30,316	)
Loan receivables received from others		2,102			5,511			—			—			7,613
Loan receivables funded to others		(7,648	)		(4,762	)		—			—			(12,410	)
Net cash used in investing activities		(5,546	)		(406,773	)		(620	)		—			(412,939	)
Financing activities
Borrowings of debt		185,000			98,000			—			—			283,000
Repayment of debt		(10,000	)		(118,000	)		(117	)		—			(128,117	)
Payment of financing costs		(4,588	)		—			—			—			(4,588	)
Capital contributions		60			—			—			—			60
Public offering proceeds		221,720			—			—			—			221,720
Cost of raising capital		(10,551	)		—			—			—			(10,551	)
Units issued for settlement of vested stock and exercised unit options, net		3,053			—			—			—			3,053
Cash distributions to partners		(56,656	)		—			—			—			(56,646	)
Net cash provided by (used in) financing activities		328,038			(20,000	)		(117	)		—			307,921
Net (decrease) increase in cash and cash equivalents		(36,020	)		1,351			(261	)		—			(34,930	)
Cash and cash equivalents:
Beginning of period		50,709			(714	)		769			—			50,764
End of period	$	14,689		$	637		$	508		$	—		$	15,834
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Nine Months Ended September 30, 2013
(in thousands)
(unaudited)
	Issuers			Subsidiary			Non-			Eliminations			Consolidated
				Guarantors			Guarantor
							Subsidiaries
Net cash (used in) provided by operating activities	$	(220,414	)	$	259,381		$	(2,572	)	$	—		$	36,395
Investing activities
Purchase of real estate		—			(38,076	)		—			—			(38,076	)
Proceeds from sales of real estate, net		—			1,772			3,070			—			4,842
Capital improvements		(6	)		(9,865	)		(38	)		—			(9,909	)
Development projects		—			(14,380	)		—			—			(14,380	)
Loan receivables received from others		2,041			1,181			—			—			3,222
Loan receivables funded to others		(370	)		(2,387	)		—			—			(2,707	)
Net cash provided by (used in) investing activities		1,665			(61,705	)		3,032			—			(57,008	)
Financing activities
Borrowings of debt		—			160,000			—			—			160,000
Repayment of debt		—			(353,091	)		(112	)		—			(353,203	)
Payment of financing costs		—			(5,290	)		—			—			(5,290	)
Capital contributions		425			—			—			—			425
Initial public offering proceeds		303,600			—			—			—			303,600
Cost of raising capital		(25,380	)		—			—			—			(25,380	)
Cash distributions to partners		(65,183	)		—			—			—			(65,183	)
Net cash provided by (used in) financing activities		213,462			(198,381	)		(112	)		—			14,969
Net increase (decrease) in cash and cash equivalents		(5,287	)		(705	)		348			—			(5,644	)
Cash and cash equivalents:
Beginning of period		16,869			(1,861	)		526			—			17,876
End of period	$	11,582		$	(2,566	)	$	874		$	—		$	12,232

Description_of_Operations_and_1

Description of Operations and Formation - Additional Information (Detail) (USD $)

0 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

0 Months Ended

Apr. 15, 2013

Mar. 07, 2013

Sep. 30, 2010

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Mar. 25, 2013

Mar. 07, 2013

Sep. 30, 2010

Sep. 30, 2014

Dec. 31, 2013

Mar. 26, 2013

Mar. 26, 2013

Property

Segment

Common Stock

Common Stock

Common Stock

IPO

IPO

Property

Consolidation And Basis Of Presentation [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Directly or indirectly owned or leased properties across the United States

'

'

'

313

'

313

'

'

'

'

'

'

'

'

'

Number of wholly owned subsidiaries

'

'

'

'

'

5

'

'

'

'

'

'

'

'

'

Authorized shares of common stock

'

'

'

300,000,000

'

300,000,000

'

'

'

'

'

'

'

'

'

Common stock, par value

'

'

'

$0.01

'

$0.01

'

$0.01

'

'

'

'

'

'

'

Authorized shares of preferred stock

'

'

'

25,000,000

'

25,000,000

'

'

'

'

'

'

'

'

'

Preferred stock, par value

'

'

'

$0.01

'

$0.01

'

'

'

'

'

'

'

'

'

Stock issued (in shares)

'

'

13,200,000

'

'

8,500,000

'

'

'

'

'

'

'

15,180,000

'

Net proceeds from issuance of shares

'

'

'

'

'

$221,720,000

$303,600,000

'

'

'

$235,000,000

$159,000,000

'

'

'

Increase in the number of authorized REIT shares

'

'

'

'

'

'

'

'

'

300,000,000

'

'

'

'

'

Common stock shares, split ratio

'

60.37

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares issued under underwritten public offering

'

'

'

47,216,963

'

47,216,963

'

37,593,910

'

'

'

'

'

'

15,200,000

Net proceeds, before expenses

'

'

'

'

'

'

'

'

'

'

'

'

'

$282,300,000

'

Shares sold to underwriters

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000

Offering price per share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$20

Common stock, shares outstanding

'

'

'

47,216,963

'

47,216,963

'

37,593,910

21,700,000

'

'

47,216,963

37,593,910

'

'

Operating Partnership unit

'

'

'

11,400,000

'

11,400,000

'

'

11,900,000

'

'

'

'

'

'

Preferred stock, shares outstanding

'

'

'

'

'

'

'

'

125

'

'

'

'

'

'

Preferred stock, redeemed

125

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Ownership of Partnership

'

'

'

80.50%

'

80.50%

'

76.40%

'

'

'

'

'

'

'

Weighted average

'

'

'

80.52%

79.15%

75.70%

73.10%

'

'

'

'

'

'

'

'

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	0 Months Ended	9 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 26, 2013	Sep. 30, 2014	Dec. 31, 2013
		PartnershipUnit
		Segment
Reportable segment	'	1	'
Reserve for uncollectible loan receivables, balance	'	$3.20	$0
Outstanding mortgage and other notes payable obligations	'	840.9	686.4
Fair values of debt	'	863.6	705.8
Outstanding loan receivables	'	43.3	41.7
Number of classes of partnerships units	'	6	'
Operating partnership converted into OP units	21,653,813	11,938,420	'
OP units outstanding	'	11,416,426	'
Maximum	'	'	'
Highly liquid short-term investments, original maturities	'	'3 months	'
Real Estate Investment	'	'	'
Uncertain income tax positions	'	$0	$0

Impairments_Recorded_to_Reflec

Impairments Recorded to Reflect Estimated Fair Values (Level 2) (Detail) (USD $)	3 Months Ended	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]	'	'
Impairment evaluation	$1,479	$2,341
Willmar, MN	'	'
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]	'	'
Impairment evaluation	'	862
Jasper,TX	'	'
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]	'	'
Impairment evaluation	'	$1,479

Components_of_Rental_Income_De

Components of Rental Income (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Cash rental income	$44,220	$32,555	$123,982	$95,111
Straight-line rental income (expense), net	1,727	-1,227	3,420	2,998
Rental income from intangible amortization, net	132	365	539	1,097
Total rental income	$46,079	$31,693	$127,941	$99,206

Rental_Property_Activity_Detai

Rental Property Activity (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Real Estate Properties [Line Items]	'	'
Property Acquired Purchase Price	$368,870	$38,076
Total Purchase Price of acquisition	383,268	'
January | SNF/ALF/ILF | MINNESOTA	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF/ALF/ILF	'
Property Acquired Purchase Price	40,000	'
January | SNF | Texas	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF	'
Property Acquired Purchase Price	15,920	'
March | SNF | Iowa	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF	'
Property Acquired Purchase Price	13,500	'
March | SNF | Kentucky	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF	'
Property Acquired Purchase Price	35,000	'
April | SNF | Texas	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF	'
Property Acquired Purchase Price	53,700	'
April | SNF | Florida	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF	'
Property Acquired Purchase Price	6,000	'
May | SNF | Texas	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF	'
Property Acquired Purchase Price	3,600	'
May | SNF | California	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF	'
Property Acquired Purchase Price	13,350	'
June | SNF | Kentucky	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF	'
Property Acquired Purchase Price	6,000	'
July | Massachusetts	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'Land Held for Development	'
Property Acquired Purchase Price	12,288	'
July | SNF | Missouri	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF	'
Property Acquired Purchase Price	16,200	'
July | ALF | Massachusetts	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'ALF	'
Property Acquired Purchase Price	32,000	'
July | SNF/ALF | Massachusetts	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF/ALF	'
Property Acquired Purchase Price	50,000	'
September | SNF/ALF | Washington/ Idaho	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'SNF/ALF	'
Property Acquired Purchase Price	83,600	'
February | Texas	'	'
Real Estate Properties [Line Items]	'	'
Real Estate property type	'Land Held for Development	'
Property Acquired Purchase Price	$2,110	'

Real_Estate_Assets_Additional_

Real Estate Assets - Additional Information (Detail) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

0 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

In Millions, unless otherwise specified

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Jul. 10, 2014

Jul. 10, 2014

Jul. 10, 2014

Jul. 10, 2014

Sep. 30, 2014

Dec. 31, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Property

Property

Massachusetts

Massachusetts

Massachusetts

Massachusetts

Reinvestment Projects Completed

Reinvestment Projects Completed

Reinvestment Projects Completed

Reinvestment Projects Completed

Construction in Progress

Construction in Progress

Series of Individually Immaterial Business Acquisitions

Series of Individually Immaterial Business Acquisitions

Property

Property

Directors, Executive Officers and Related Interests

Directors, Executive Officers and Related Interests

Investment

Investment

California

California, Pennsylvania, Texas and Indiana

Property

Property

Real Estate Properties [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of properties acquired

313

'

313

'

'

3

'

'

'

'

1

6

'

'

'

'

Number of land parcels acquired

'

'

'

'

2

'

'

'

'

'

'

'

'

'

'

'

Property acquired purchase price

'

'

'

'

$94.30

'

'

'

'

'

'

'

'

'

'

'

Percentage of equity interest in sellers properties

'

'

'

'

'

'

'

50.00%

'

'

'

'

'

'

'

'

Gross economic interest in sellers properties

'

'

'

'

'

'

47.1

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7.5

13.5

Net Income

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.5

7.2

Acquisition costs

0.7

'

2.4

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of real estate property disposed

5

'

7

'

'

'

'

'

'

'

'

'

'

'

'

'

Property sold

0.8

'

1.4

'

'

'

'

'

'

'

'

'

'

'

'

'

Net loss on sale of properties

-2.4

'

-2.5

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average interest rate on all outstanding debt

6.00%

'

6.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

Capitalized interest

$0.20

$0.20

$0.50

$0.40

'

'

'

'

'

'

'

'

$0.70

$0.80

'

'

Number of completed investment projects placed into services

'

'

'

'

'

'

'

'

6

1

'

'

'

'

'

'

Effect_on_Revenues_and_Net_Inc

Effect on Revenues and Net Income (Detail) (Series of Individually Immaterial Business Acquisitions, USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Series of Individually Immaterial Business Acquisitions	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Total revenues	$48,795	$41,831	$145,811	$129,480
Net income	$13,874	$16,442	$43,838	$31,173

Net_Purchase_Price_Paid_Detail

Net Purchase Price Paid (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Real Estate Properties [Line Items]	'
Borrowings withdrawn for acquisition	$383,268
Land	'
Real Estate Properties [Line Items]	'
Borrowings withdrawn for acquisition	33,390
Building and improvements	'
Real Estate Properties [Line Items]	'
Borrowings withdrawn for acquisition	310,390
Furniture, Fixtures and equipment	'
Real Estate Properties [Line Items]	'
Borrowings withdrawn for acquisition	25,090
Construction in Progress and Land Held for Development	'
Real Estate Properties [Line Items]	'
Borrowings withdrawn for acquisition	$14,398

Construction_in_Progress_Detai

Construction in Progress (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Property, Plant and Equipment [Line Items]	'
Beginning balance	$23,292
Additions	31,170
Placed in service	-20,041
Ending balance	$34,421

Loan_Receivables_Detail

Loan Receivables (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Loans Receivable [Line Items]	'
Beginning balance	$41,686
New loans issued	12,410
Reserve for uncollectible loans	-3,211
Loan amortization and repayments	-7,613
Ending balance	43,272
Mortgage loans	'
Loans Receivable [Line Items]	'
Beginning balance	28,316
New loans issued	4,762
Loan amortization and repayments	-5,394
Ending balance	27,684
Capital Improvement Loans	'
Loans Receivable [Line Items]	'
Beginning balance	4,580
Loan amortization and repayments	-760
Ending balance	3,820
Working Capital Loans	'
Loans Receivable [Line Items]	'
Beginning balance	8,790
New loans issued	7,648
Reserve for uncollectible loans	-3,211
Loan amortization and repayments	-1,459
Ending balance	$11,768

Interest_Income_on_Loans_and_F

Interest Income on Loans and Financing Leases (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Interest and Other Income [Line Items]	'	'	'	'
Interest on loans and financing lease	$1,101	$1,131	$3,263	$3,272
Mortgage loans	'	'	'	'
Interest and Other Income [Line Items]	'	'	'	'
Interest on loans and financing lease	456	472	1,364	1,208
Capital Improvement Loans	'	'	'	'
Interest and Other Income [Line Items]	'	'	'	'
Interest on loans and financing lease	66	117	267	417
Working Capital Loans	'	'	'	'
Interest and Other Income [Line Items]	'	'	'	'
Interest on loans and financing lease	211	177	529	556
Direct Financing Leases	'	'	'	'
Interest and Other Income [Line Items]	'	'	'	'
Interest on loans and financing lease	$368	$365	$1,103	$1,091

Loan_Receivables_Additional_In

Loan Receivables - Additional Information (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Loans Receivable [Line Items]	'	'
Reserve for uncollectible loan receivables, balance	$3.20	$0
Gross balance of loan receivables for which a reserve on a loan-by-loan basis for uncollectible loan receivables has been applied	$3.20	$0

Deferred_Finance_Costs_Detail

Deferred Finance Costs (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Line Items]	'	'
Gross amount	$25,531	$21,881
Accumulated amortization	-7,880	-5,238
Net	$17,651	$16,643

Deferred_Finance_Costs_Additio

Deferred Finance Costs - Additional Information (Detail) (USD $)	3 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Line Items]	'	'
Amortization of deferred financing costs	$0	$0.80
Accumulated amortization associated with the Construction Loan	0	0.3
Net recognition as loss on extinguishment of debt	$0	$0.50

Intangible_Assets_and_Liabilit2

Intangible Assets and Liabilities Classified as Part of Other Assets or Other Liabilities (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Intangible Assets Goodwill And Other Assets [Line Items]	'	'
Gross Amount	$6,376	$7,301
Accumulated Amortization	-3,056	-3,616
Net	3,320	3,685
Above Market Leases	'	'
Intangible Assets Goodwill And Other Assets [Line Items]	'	'
Gross Amount	5,512	6,437
Accumulated Amortization	-2,830	-3,452
Net	2,682	2,985
Leases, Acquired-in-Place	'	'
Intangible Assets Goodwill And Other Assets [Line Items]	'	'
Gross Amount	652	652
Accumulated Amortization	-179	-130
Net	473	522
Operator Relationships	'	'
Intangible Assets Goodwill And Other Assets [Line Items]	'	'
Gross Amount	212	212
Accumulated Amortization	-47	-34
Net	165	178
Market Leases Below	'	'
Intangible Assets Goodwill And Other Assets [Line Items]	'	'
Gross Amount	12,933	17,623
Accumulated Amortization	-6,212	-10,059
Net	$6,721	$7,564

Intangible_Assets_and_Liabilit3

Intangible Assets and Liabilities - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Intangible Assets Goodwill And Other Assets [Line Items]	'	'	'	'
Net recognition in rental income	$0	'	$0	'
Leases, Acquired-in-Place	'	'	'	'
Intangible Assets Goodwill And Other Assets [Line Items]	'	'	'	'
Amortization expense	0.02	0.02	0.06	0.06
Above Market Leases	'	'	'	'
Intangible Assets Goodwill And Other Assets [Line Items]	'	'	'	'
Amortization expense	0.09	0.1	0.3	0.4
Amount of partnership wrote-off	0.3	'	0.9	'
Market Leases Below	'	'	'	'
Intangible Assets Goodwill And Other Assets [Line Items]	'	'	'	'
Accretion	0.2	0.5	0.8	1.5
Amount of partnership wrote-off	$0.30	'	$4.70	'

Leases_Additional_Information_

Leases - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
	Property		Property
	Person		Person
	Entity		Entity
	State		State
Operating Leased Assets [Line Items]	'	'	'	'
Number of real estate properties acquired	313	'	313	'
Number of States in which Entity Operates	29	'	29	'
Number of third party operators	38	'	38	'
Total Assets leased to private operators	53.60%	'	53.60%	'
Number of operators taken assets on lease	5	'	5	'
Percentage of assets representation range maximum	5.30%	'	5.30%	'
Rental income	$46,079,000	$31,693,000	$127,941,000	$99,206,000
Maximum rental income generated by another operator	'	'	7.50%	'
Texas	'	'	'	'
Operating Leased Assets [Line Items]	'	'	'	'
Assets in different states	16.90%	'	16.90%	'
Ohio	'	'	'	'
Operating Leased Assets [Line Items]	'	'	'	'
Assets in different states	12.10%	'	12.10%	'
California	'	'	'	'
Operating Leased Assets [Line Items]	'	'	'	'
Assets in different states	10.70%	'	10.70%	'
Washington	'	'	'	'
Operating Leased Assets [Line Items]	'	'	'	'
Assets in different states	7.00%	'	7.00%	'
Connecticut	'	'	'	'
Operating Leased Assets [Line Items]	'	'	'	'
Assets in different states	6.50%	'	6.50%	'
Saber Health Group	'	'	'	'
Operating Leased Assets [Line Items]	'	'	'	'
Assets held by operators	11.40%	'	11.40%	'
Rental income from operators	'	'	16,300,000	'
Rental income from operators, in percentage	'	'	12.70%	'
Daybreak Healthcare	'	'	'	'
Operating Leased Assets [Line Items]	'	'	'	'
Assets held by operators	9.60%	'	9.60%	'
Rental income from operators	'	'	17,000,000	'
Rental income from operators, in percentage	'	'	13.30%	'
Fundamental	'	'	'	'
Operating Leased Assets [Line Items]	'	'	'	'
Assets held by operators	8.40%	'	8.40%	'
Maplewood	'	'	'	'
Operating Leased Assets [Line Items]	'	'	'	'
Assets held by operators	13.10%	'	13.10%	'
EmpRes	'	'	'	'
Operating Leased Assets [Line Items]	'	'	'	'
Assets held by operators	11.10%	'	11.10%	'
Rental income from operators	'	'	$9,900,000	'
Rental income from operators, in percentage	'	'	7.70%	'

Components_of_Secured_LoansUns

Components of Secured Loans,Unsecured Notes Payable and Line of Credit (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Instrument [Line Items]	'	'
Term loan and other notes payable	$840,888	$686,406
HUD Loan	'	'
Debt Instrument [Line Items]	'	'
Term loan and other notes payable	13,478	13,654
2019 Notes	'	'
Debt Instrument [Line Items]	'	'
Term loan and other notes payable	402,410	402,752
2021 Notes	'	'
Debt Instrument [Line Items]	'	'
Term loan and other notes payable	250,000	250,000
Unsecured Revolving Credit Facility	'	'
Debt Instrument [Line Items]	'	'
Term loan and other notes payable	175,000	'
Revolving Credit Facility	'	'
Debt Instrument [Line Items]	'	'
Term loan and other notes payable	'	$20,000

Components_of_Secured_LoansUns1

Components of Secured Loans,Unsecured Notes Payable and Line of Credit (Parenthetical) (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Jun. 15, 2012	Sep. 30, 2014	Dec. 31, 2013	Mar. 28, 2012	Apr. 05, 2011	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	HUD Loan	HUD Loan	HUD Loan	2019 Notes	2019 Notes	2019 Notes	2019 Notes	2021 Notes	2021 Notes	Unsecured Revolving Credit Facility	Revolving Credit Facility
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Interest rate of debt	5.00%	5.00%	'	7.75%	7.75%	'	'	6.00%	6.00%	1.85%	'
Premium paid on issuance of senior notes	$2.40	$2.40	$2.50	$2.40	$2.80	$1	$2.75	'	'	'	'
Interest rate of debt	'	'	'	7.75%	'	'	'	'	6.00%	'	2.52%

Debt_Additional_Information_De

Debt - Additional Information (Detail) (USD $)

9 Months Ended

0 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Apr. 16, 2013

Mar. 26, 2013

Mar. 26, 2013

Sep. 30, 2014

14-May-14

14-May-14

14-May-14

14-May-14

Sep. 30, 2014

Dec. 31, 2013

Mar. 28, 2012

Apr. 05, 2011

Feb. 04, 2011

Dec. 31, 2013

Oct. 16, 2013

Jun. 15, 2012

Sep. 30, 2014

Dec. 31, 2013

Jun. 15, 2012

LIBOR

LIBOR

Revolving Credit Facility

Revolving Credit Facility

Term Loans

Unsecured Revolving Credit Facility

Unsecured Revolving Credit Facility

Unsecured Revolving Credit Facility

Unsecured Revolving Credit Facility

Unsecured Revolving Credit Facility

2019 Notes

2019 Notes

2019 Notes

2019 Notes

2019 Notes

2021 Notes

2021 Notes

HUD Loan

HUD Loan

HUD Loan

HUD Loan

Minimum

Maximum

Upon satisfaction of certain conditions

LIBOR

LIBOR

Minimum

Maximum

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Senior notes issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$100,000,000

$100,000,000

$200,000,000

'

$250,000,000

'

'

'

'

Debt instrument interest rate percentage

'

'

'

'

'

'

'

'

'

'

'

'

7.75%

'

'

'

'

6.00%

'

'

'

'

'

Premium paid on issuance of debt

'

'

'

'

'

'

'

'

'

'

'

'

2,400,000

2,800,000

1,000,000

2,750,000

'

'

'

'

2,400,000

2,400,000

2,500,000

Loan maturity period

'

'

'

'

'

'

'

'

'

'

'

'

15-Feb-19

'

'

'

'

15-Oct-21

'

'

'

'

'

Repayment of long-term debt

128,117,000

353,203,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

135,000,000

'

'

'

'

'

Revolving credit facility, maximum borrowing capacity

'

'

'

'

400,000,000

300,000,000

'

'

600,000,000

800,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Revolving credit facility, additional borrowing capacity

'

'

'

'

'

100,000,000

100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revolving credit facility, margin on variable rate

'

'

2.35%

3.00%

'

'

'

'

'

'

1.70%

2.25%

'

'

'

'

'

'

'

'

'

'

'

Revolving credit facility unused capacity commitment fee

0.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revolving credit facility, outstanding

'

'

'

'

'

'

'

175,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Subsidiary of Aviv Financing III assumed a HUD loan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$11,500,000

Interest, fixed rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5.00%

Debt Instrument Amortization Periods

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'35 years

'

'

'

Commitments_and_Contingencies_

Commitments and Contingencies - Additional Information (Detail) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014
Purchase Option One	'
Commitment And Contingencies [Line Items]	'
Number of tenants with purchase options	1
Purchase Option One | Exercisable Period One	'
Commitment And Contingencies [Line Items]	'
Number of properties with purchase options	5
Purchase Option One | Exercisable Period One | Minimum	'
Commitment And Contingencies [Line Items]	'
Purchase option, exercisable period	1-Jan-17
Purchase Option One | Exercisable Period Two	'
Commitment And Contingencies [Line Items]	'
Number of properties with purchase options	2
Purchase Option One | Exercisable Period Two | Minimum	'
Commitment And Contingencies [Line Items]	'
Purchase option, exercisable period	1-Jan-19
Purchase Option One | Exercisable Period Three	'
Commitment And Contingencies [Line Items]	'
Number of properties with purchase options	5
Purchase Option One | Exercisable Period Three | Minimum	'
Commitment And Contingencies [Line Items]	'
Purchase option, exercisable period	1-Jan-22
Purchase Option Two	'
Commitment And Contingencies [Line Items]	'
Number of tenants with purchase options	4
Number of properties with purchase options	5
Purchase Option Two | Exercisable at Predetermined Purchase Price	'
Commitment And Contingencies [Line Items]	'
Number of properties with purchase options	2
Purchase Option Two | Exercisable at Purchase Price to be Determined at Future Date	'
Commitment And Contingencies [Line Items]	'
Number of properties with purchase options	3
2012 Activity Not Previously Reserved	'
Commitment And Contingencies [Line Items]	'
Number of operators with contractual arrangements	3
Number of facilities with contractual arrangements	6
Obligation for fees	2.6
Obligation paid	2.1
Accrued as a component of other liabilities	0.5

Noncontrolling_Interests_Opera

Noncontrolling Interests - Operating Partnership / OP Units - Additional Information (Detail)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013
Distribution Made to Limited Partner [Line Items]	'	'	'
Operating partnership units redeemed	26,885	199,856	0

Summary_of_Distributions_Accru

Summary of Distributions Accrued in Accordance with Declaration to Partnership's Partners (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Distribution Made to Limited Partner [Line Items]	'	'	'	'
Distributions to the Partnership's partners	'	'	$12,374	'
Operating Partnership Units	'	'	'	'
Distribution Made to Limited Partner [Line Items]	'	'	'	'
Distributions to the Partnership's partners	4,110	4,298	12,374	8,882
Common Stock	'	'	'	'
Distribution Made to Limited Partner [Line Items]	'	'	'	'
Distributions to the Partnership's partners	17,009	13,435	47,666	34,286
Class A	'	'	'	'
Distribution Made to Limited Partner [Line Items]	'	'	'	'
Distributions to the Partnership's partners	'	'	'	2,797
Class B	'	'	'	'
Distribution Made to Limited Partner [Line Items]	'	'	'	'
Distributions to the Partnership's partners	'	'	'	97
Class C	'	'	'	'
Distribution Made to Limited Partner [Line Items]	'	'	'	'
Distributions to the Partnership's partners	'	'	'	146
Class F	'	'	'	'
Distribution Made to Limited Partner [Line Items]	'	'	'	'
Distributions to the Partnership's partners	'	'	'	$554

Stockholders_Equity_of_REIT_an

Stockholders' Equity of REIT and Partners' Capital of OP - Additional Information (Detail) (USD $)	0 Months Ended	1 Months Ended	3 Months Ended	9 Months Ended		0 Months Ended		9 Months Ended		0 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 26, 2013	Sep. 30, 2010	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Mar. 26, 2013	Apr. 15, 2014	Sep. 30, 2014	Sep. 30, 2013	Mar. 26, 2013
						IPO	Underwritten Public Offering	Board of Directors	Board of Directors	Other Investors of Partnership
Distribution Made to Limited Partner [Line Items]	'	'	'	'	'	'	'	'	'	'
Operating partnership converted into OP units	21,653,813	'	'	11,938,420	'	'	'	'	'	11,938,420
Shares of the Company's common stock issued (in shares)	'	'	'	16,361	0	'	'	16,618	70,000	'
Shares reserved for issuance	'	'	156,397	156,397	0	'	'	'	'	'
Stock issued (in shares)	'	13,200,000	'	8,500,000	'	15,180,000	9,200,000	'	'	'
Net proceeds from IPO	'	'	'	'	'	$282,300	'	'	'	'
Net proceeds from issuance of shares	'	'	'	$221,720	$303,600	'	$211,300	'	'	'
Operating partnership units redeemed	'	'	26,885	199,856	0	'	'	'	'	'
Common stock shares issued	'	'	'	174,467	0	'	'	'	'	'

Summary_of_WeightedAverage_Uni

Summary of Weighted-Average Units and Shares Outstanding (Detail)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Operating Partnership Units	'	'	'	'
Weighted-average Units outstanding	'	'	'	'
Weighted Average General Partnership Units Outstanding	11,419,777	11,938,420	11,478,543	8,221,330
Common Stock	'	'	'	'
Weighted-average Units outstanding	'	'	'	'
Weighted Average General Partnership Units Outstanding	47,213,612	37,271,714	43,576,705	32,408,843
Class A	'	'	'	'
Weighted-average Units outstanding	'	'	'	'
Weighted Average General Partnership Units Outstanding	'	'	'	4,193,031
Class B	'	'	'	'
Weighted-average Units outstanding	'	'	'	'
Weighted Average General Partnership Units Outstanding	'	'	'	1,408,305
Class D	'	'	'	'
Weighted-average Units outstanding	'	'	'	'
Weighted Average General Partnership Units Outstanding	'	'	'	2,506
Class F	'	'	'	'
Weighted-average Units outstanding	'	'	'	'
Weighted Average General Partnership Units Outstanding	'	'	'	835,958

Summary_of_Dividends_Declared_

Summary of Dividends Declared and Paid (Detail) (USD $)	0 Months Ended		3 Months Ended
	Sep. 26, 2014	Jun. 27, 2014	Mar. 31, 2014	Sep. 30, 2014	Sep. 26, 2014	Jun. 27, 2014
Dividend Declared [Line Items]	'	'	'	'	'	'
Declaration Date	29-Jul-14	27-May-14	18-Mar-14	'	'	'
Record Date	26-Sep-14	27-Jun-14	31-Mar-14	'	'	'
Amount Per Share	'	'	$0.36	$1.08	$0.36	$0.36
Dividend Payment Date	10-Oct-14	11-Jul-14	11-Apr-14	'	'	'

Equity_Compensation_Plan_Addit

Equity Compensation Plan - Additional Information (Detail) (USD $)

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

26-May-13

Mar. 26, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

26-May-13

Dec. 31, 2012

Mar. 26, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Mar. 26, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Class D

Long Term Incentive Plans

Long Term Incentive Plans

Long Term Incentive Plans

Long Term Incentive Plans

Long Term Incentive Plans

Long Term Incentive Plans

Long Term Incentive Plans

Long Term Incentive Plans

Long Term Incentive Plans

Long Term Incentive Plans

Long Term Incentive Plans

Long Term Incentive Plans

Management Incentive Plan

Management Incentive Plan

Management Incentive Plan

Management Incentive Plan

Restricted Stock Awards

Restricted Stock Awards

Restricted Stock Units (RSUs)

Restricted Stock Units (RSUs)

Restricted Stock Units (RSUs)

Restricted Stock Units (RSUs)

Minimum

Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Non-cash stock-based compensation expense

'

'

'

'

'

'

'

'

'

$900,000

$900,000

$500,000

$3,600,000

$600,000

'

'

'

'

'

'

'

'

$0

$0

$0

$9,000,000

Shares available for issuance

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

Shares of the Company's common stock issued (in shares)

'

'

'

'

16,361

0

'

'

'

'

'

'

'

'

23,250

'

'

'

156,397

226,585

'

'

'

'

'

'

Shares issued and vested

'

'

'

'

40,055

[1]

'

'

'

'

'

'

'

'

'

'

'

15,750

'

16,361

'

'

'

'

'

'

'

Shares issued and subject to vesting period

'

'

362,228

182,092

362,228

182,092

256,092

'

'

'

'

'

'

'

'

'

'

47,250

'

'

'

'

'

'

'

'

Forfeited shares

'

'

'

'

26,724

'

'

'

'

'

'

'

'

'

'

'

'

'

7,779

17,470

'

'

'

'

'

'

Vesting period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2 years

'3 years

'

'

'

'

Forfeited shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18,445

'

'

'

'

'

'

'

Total unearned compensation on restricted stock

'

'

6,500,000

'

6,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted average vesting period

'

'

'

'

'1 year 9 months 4 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate fair value of performance based award

'

'

'

'

'

'

'

7,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options granted service period

'4 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Option vesting Percentage

25.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding

'

'

5,695,671

5,870,138

5,695,671

5,870,138

5,870,138

5,870,138

1,956,713

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted average exercise price

'

'

'

'

'

'

'

$17.47

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividend paid in shares

14,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Withholding For share based Compensation

6,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividend distributions declared

'

14.90%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividend distribution paid

'

'

'

'

3,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of options awarded

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unrecognized compensation cost

'

'

0

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividend equivalent rights payable upon vesting

'

'

$0

$0

$0

$15,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

[1]

Includes 7,944 shares which were used to settle minimum employee withholding tax obligations for one employee of approximately $0.2 million in 2014. A net of 32,111 shares of common stock were delivered in the nine months ended September 30, 2014.

Number_of_Unvested_Shares_of_R

Number of Unvested Shares of Restricted Stock and Weighted Average Fair Value of Shares at Date of Grant (Detail) (USD $)	9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013
Shares of Restricted Stock	'		'
Beginning balance	256,092		'
Granted	172,915		182,092
Vested	-40,055	[1]	'
Forfeited	-26,724		'
Ending balance	362,228		182,092
Weighted average fair value of date of grant	'		'
Beginning balance	$29.83		'
Granted	$26.55		$33.10
Vested	$23.08	[1]	'
Forfeited	$30.53		'
Ending balance	$28.96		$33.10
[1]	Includes 7,944 shares which were used to settle minimum employee withholding tax obligations for one employee of approximately $0.2 million in 2014. A net of 32,111 shares of common stock were delivered in the nine months ended September 30, 2014.

Number_of_Unvested_Shares_of_R1

Number of Unvested Shares of Restricted Stock and Weighted Average Fair Value of Shares at Date of Grant (Parenthetical) (Detail) (USD $)	9 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 30, 2014
	Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares used to settle minimum employee withholding tax obligations	7,944
Number of employee that shares used to settle minimum employee withholding tax obligations	1
Value of shares used to settle minimum employee withholding tax obligations	$0.20
Shares of common stock delivered net	32,111

Time_Based_Option_Awards_Activ

Time Based Option Awards Activity (Detail) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	26-May-13
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Outstanding at beginning of period	5,870,138	1,956,713	5,870,138
Exercised	-174,467	0	'
Awards vested at IPO	'	3,913,425	'
Outstanding at end of period	5,695,671	5,870,138	5,870,138
Options exercisable at end of period	5,695,671	'	'
Weighted average fair value of options granted	$2.20	$2.20	'

Time_Based_Option_Awards_Outst

Time Based Option Awards Outstanding (Detail) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Range of exercise prices lower limit	$16.56	$16.56
Range of exercise prices upper limit	$18.87	$18.87
Outstanding	5,695,671	5,870,138
Remaining contractual life (years)	'6 years 6 months 7 days	'7 years 6 months 18 days
Weighted average exercise price	$17.44	$17.47

Computing_Basic_and_Diluted_Ea

Computing Basic and Diluted Earnings Per Common Share (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Numerator for earnings per common share-basic:	'	'	'	'
Net income	$12,035	$10,067	$31,951	$12,031
Net income allocable to noncontrolling interests - operating partnership	-2,344	-2,446	-6,662	-3,236
Numerator for earnings per common share/unit - basic	9,691	7,621	25,289	8,795
Numerator for earnings per common share/unit - diluted:	'	'	'	'
Numerator for earnings per common share/unit - basic	9,691	7,621	25,289	8,795
Net income allocable to noncontrolling interests-OP units	2,344	2,446	6,662	2,228
Numerator for earnings per common share/unit - diluted	$12,035	$10,067	$31,951	$11,023
Denominator for earnings per common share/unit - basic and diluted:	'	'	'	'
Denominator for earnings per common share/unit - basic	47,213,612	37,271,714	43,576,705	32,408,843
Effect of dilutive securities:	'	'	'	'
Noncontrolling interests-OP units	11,419,777	11,938,420	11,478,543	8,221,330
Denominator for earnings per common share/unit - diluted	60,967,867	50,838,529	57,127,784	42,101,077
Basic earnings per share/unit:	'	'	'	'
Net income allocable to common stockholders	$0.21	$0.20	$0.58	$0.27
Diluted earnings per share/unit:	'	'	'	'
Net income allocable to common stockholders	$0.20	$0.20	$0.56	$0.26
Stock Option	'	'	'	'
Effect of dilutive securities:	'	'	'	'
Incremental to dilutive securities	2,155,075	1,599,302	1,953,632	1,454,735
Restricted Stock Units (RSUs)	'	'	'	'
Effect of dilutive securities:	'	'	'	'
Incremental to dilutive securities	179,403	29,093	118,904	16,169

Computing_Basic_and_Diluted_Ea1

Computing Basic and Diluted Earnings Per Common Unit (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Numerator for earnings per unit-basic:	'	'	'	'
Net income	$12,035	$10,067	$31,951	$12,031
Net income allocable to limited partners	-2,344	-2,446	-6,662	-3,236
Numerator for earnings per share/unit - basic	9,691	7,621	25,289	8,795
Numerator for earnings per share/unit - diluted:	'	'	'	'
Numerator for earnings per share/unit - diluted	12,035	10,067	31,951	11,023
Denominator for earnings per share/unit - basic and diluted:	'	'	'	'
Denominator for basic earnings per share/unit - basic	47,213,612	37,271,714	43,576,705	32,408,843
Effective dilutive securities:	'	'	'	'
Denominator for earnings per share/unit - diluted	60,967,867	50,838,529	57,127,784	42,101,077
Basic earnings per share/unit:	'	'	'	'
Net income allocable to units	$0.21	$0.20	$0.58	$0.27
Diluted earnings per share/unit:	'	'	'	'
Net income allocable to units	$0.20	$0.20	$0.56	$0.26
Stock Option	'	'	'	'
Effective dilutive securities:	'	'	'	'
Incremental to dilutive securities	2,155,075	1,599,302	1,953,632	1,454,735
Restricted Stock Units (RSUs)	'	'	'	'
Effective dilutive securities:	'	'	'	'
Incremental to dilutive securities	179,403	29,093	118,904	16,169
Aviv Healthcare Properties Limited Partnership	'	'	'	'
Numerator for earnings per unit-basic:	'	'	'	'
Net income	12,035	10,067	31,951	12,031
Net income allocable to limited partners	'	'	'	-1,008
Numerator for earnings per share/unit - basic	12,035	10,067	31,951	11,023
Numerator for earnings per share/unit - diluted:	'	'	'	'
Numerator for earnings per share/unit - diluted	$12,035	$10,067	$31,951	$11,023
Denominator for earnings per share/unit - basic and diluted:	'	'	'	'
Denominator for basic earnings per share/unit - basic	58,633,389	49,210,134	55,055,248	40,630,173
Effective dilutive securities:	'	'	'	'
Denominator for earnings per share/unit - diluted	60,967,867	50,838,529	57,127,784	42,101,077
Basic earnings per share/unit:	'	'	'	'
Net income allocable to units	$0.21	$0.20	$0.58	$0.27
Diluted earnings per share/unit:	'	'	'	'
Net income allocable to units	$0.20	$0.20	$0.56	$0.26
Aviv Healthcare Properties Limited Partnership | Stock Option	'	'	'	'
Effective dilutive securities:	'	'	'	'
Incremental to dilutive securities	2,155,075	1,599,302	1,953,632	1,454,735
Aviv Healthcare Properties Limited Partnership | Restricted Stock Units (RSUs)	'	'	'	'
Effective dilutive securities:	'	'	'	'
Incremental to dilutive securities	179,403	29,093	118,904	16,169

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (USD $)	Sep. 30, 2014	Oct. 30, 2014	Oct. 01, 2014	Oct. 01, 2014	Oct. 17, 2014	Oct. 17, 2014
In Millions, except Share data, unless otherwise specified	Property	Subsequent Event	Subsequent Event	Subsequent Event	Subsequent Event	Subsequent Event
		Omega	Kentucky	Kentucky	Texas	Texas
				Property		Property
Subsequent Event [Line Items]	'	'	'	'	'	'
Property acquired purchase price	'	'	$4.60	'	$28.50	'
Number of properties acquired	313	'	'	1	'	2
Common stock outstanding share to be received upon conversion	'	0.9	'	'	'	'

Condensed_Consolidating_Balanc

Condensed Consolidating Balance Sheet (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Net real estate	$1,538,915	$1,163,488	'	'
Cash and cash equivalents	15,834	50,764	12,232	17,876
Deferred finance costs, net	17,651	16,643	'	'
Other assets	15,805	15,625	'	'
Total assets	1,677,488	1,330,433	'	'
Secured loan	13,478	13,654	'	'
Unsecured loan	652,410	652,752	'	'
Line of credit	175,000	20,000	'	'
Accrued interest payable	10,903	15,284	'	'
Dividends and distributions payable	21,078	17,694	'	'
Accounts payable and accrued expenses	11,894	10,555	'	'
Tenant security and escrow deposits	24,066	21,586	'	'
Other liabilities	10,419	10,463	'	'
Total liabilities	919,248	761,988	'	'
Total liabilities and equity	1,677,488	1,330,433	'	'
Aviv Healthcare Properties Limited Partnership	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Net real estate	1,538,915	1,163,488	'	'
Cash and cash equivalents	15,834	50,764	12,232	17,876
Deferred finance costs, net	17,651	16,643	'	'
Other assets	105,088	99,538	'	'
Total assets	1,677,488	1,330,433	'	'
Secured loan	13,478	13,654	'	'
Unsecured loan	652,410	652,752	'	'
Line of credit	175,000	20,000	'	'
Accrued interest payable	10,903	15,284	'	'
Dividends and distributions payable	21,078	17,694	'	'
Accounts payable and accrued expenses	11,894	10,555	'	'
Tenant security and escrow deposits	24,066	21,586	'	'
Other liabilities	10,419	10,463	'	'
Total liabilities	919,248	761,988	'	'
Total partners' capital	758,240	568,445	'	'
Total liabilities and equity	1,677,488	1,330,433	'	'
Aviv Healthcare Properties Limited Partnership | Issuers	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Net real estate	49	55	'	'
Cash and cash equivalents	14,689	50,709	11,582	16,869
Deferred finance costs, net	17,637	12,681	'	'
Other assets	27,042	25,260	'	'
Investment in and due from related parties, net	1,560,447	1,168,729	'	'
Total assets	1,619,864	1,257,434	'	'
Unsecured loan	652,410	652,752	'	'
Line of credit	175,000	'	'	'
Accrued interest payable	10,857	14,750	'	'
Dividends and distributions payable	21,078	17,694	'	'
Accounts payable and accrued expenses	987	2,082	'	'
Tenant security and escrow deposits	140	765	'	'
Other liabilities	1,152	946	'	'
Total liabilities	861,624	688,989	'	'
Total partners' capital	758,240	568,445	'	'
Total liabilities and equity	1,619,864	1,257,434	'	'
Aviv Healthcare Properties Limited Partnership | Subsidiary Guarantors	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Net real estate	1,523,158	1,148,057	'	'
Cash and cash equivalents	637	-714	-2,566	-1,861
Deferred finance costs, net	'	3,948	'	'
Other assets	75,088	71,372	'	'
Total assets	1,598,883	1,222,663	'	'
Line of credit	'	20,000	'	'
Accrued interest payable	'	487	'	'
Accounts payable and accrued expenses	10,885	8,473	'	'
Tenant security and escrow deposits	23,684	20,572	'	'
Other liabilities	9,267	9,517	'	'
Total liabilities	43,836	59,049	'	'
Total partners' capital	1,555,047	1,163,614	'	'
Total liabilities and equity	1,598,883	1,222,663	'	'
Aviv Healthcare Properties Limited Partnership | Non-Guarantor Subsidiaries	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Net real estate	15,708	15,376	'	'
Cash and cash equivalents	508	769	874	526
Deferred finance costs, net	14	14	'	'
Other assets	2,958	2,906	'	'
Total assets	19,188	19,065	'	'
Secured loan	13,478	13,654	'	'
Accrued interest payable	46	47	'	'
Accounts payable and accrued expenses	22	'	'	'
Tenant security and escrow deposits	242	249	'	'
Total liabilities	13,788	13,950	'	'
Total partners' capital	5,400	5,115	'	'
Total liabilities and equity	19,188	19,065	'	'
Eliminations | Aviv Healthcare Properties Limited Partnership	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Investment in and due from related parties, net	-1,560,447	-1,168,729	'	'
Total assets	-1,560,447	-1,168,729	'	'
Total partners' capital	-1,560,447	-1,168,729	'	'
Total liabilities and equity	($1,560,447)	($1,168,729)	'	'

Condensed_Consolidating_Statem

Condensed Consolidating Statement of Operations (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues	'	'	'	'
Rental income	$46,079	$31,693	$127,941	$99,206
Interest on loans and financing lease	1,101	1,131	3,263	3,272
Interest and other income	191	49	1,232	128
Total revenues	47,371	32,873	132,436	102,606
Expenses	'	'	'	'
Interest expense incurred	12,376	8,577	36,489	29,599
Amortization of deferred financing costs	988	810	2,944	2,516
Depreciation and amortization	11,522	8,302	31,470	24,399
General and administrative	5,297	3,867	16,960	21,150
Transaction costs	1,220	1,210	3,813	1,906
Loss on impairment	1,479	'	2,341	'
Reserve for uncollectible loan receivables and other receivables	9	27	3,509	57
Loss (gain) on sale of assets, net	2,445	13	2,458	-26
Loss on extinguishment of debt	'	'	501	10,974
Total expenses	35,336	22,806	100,485	90,575
Net income	12,035	10,067	31,951	12,031
Aviv Healthcare Properties Limited Partnership	'	'	'	'
Revenues	'	'	'	'
Rental income	46,079	31,693	127,941	99,206
Interest on loans and financing lease	1,101	1,131	3,263	3,272
Interest and other income	191	49	1,232	128
Total revenues	47,371	32,873	132,436	102,606
Expenses	'	'	'	'
Interest expense incurred	12,376	8,577	36,489	29,599
Amortization of deferred financing costs	988	810	2,944	2,516
Depreciation and amortization	11,522	8,302	31,470	24,399
General and administrative	5,297	3,867	16,960	21,150
Transaction costs	1,220	1,210	3,813	1,906
Loss on impairment	1,479	'	2,341	'
Reserve for uncollectible loan receivables and other receivables	9	27	3,509	57
Loss (gain) on sale of assets, net	2,445	13	2,458	-26
Loss on extinguishment of debt	'	'	501	10,974
Total expenses	35,336	22,806	100,485	90,575
Net (loss) income	12,035	10,067	31,951	12,031
Net income	12,035	10,067	31,951	12,031
Aviv Healthcare Properties Limited Partnership | Eliminations	'	'	'	'
Expenses	'	'	'	'
Equity in income (loss) of subsidiaries	-27,010	-19,746	-78,139	-49,642
Net income	-27,010	-19,746	-78,139	-49,642
Aviv Healthcare Properties Limited Partnership | Issuers	'	'	'	'
Revenues	'	'	'	'
Interest on loans and financing lease	278	262	727	836
Interest and other income	8	'	482	5
Total revenues	286	262	1,209	841
Expenses	'	'	'	'
Interest expense incurred	12,237	7,641	34,903	22,932
Amortization of deferred financing costs	988	369	2,288	1,094
Depreciation and amortization	2	2	6	4
General and administrative	1,982	1,393	6,855	13,714
Transaction costs	52	536	134	718
Reserve for uncollectible loan receivables and other receivables	'	'	3,211	-10
Total expenses	15,261	9,941	47,397	38,452
Net (loss) income	-14,975	-9,679	-46,188	-37,611
Equity in income (loss) of subsidiaries	27,010	19,746	78,139	49,642
Net income	12,035	10,067	31,951	12,031
Aviv Healthcare Properties Limited Partnership | Subsidiary Guarantors	'	'	'	'
Revenues	'	'	'	'
Rental income	45,715	31,005	126,869	96,666
Interest on loans and financing lease	823	869	2,536	2,436
Interest and other income	183	49	750	123
Total revenues	46,721	31,923	130,155	99,225
Expenses	'	'	'	'
Interest expense incurred	'	795	1,167	6,200
Amortization of deferred financing costs	'	441	656	1,422
Depreciation and amortization	11,414	8,130	31,155	23,881
General and administrative	3,301	2,458	10,044	7,364
Transaction costs	1,168	674	3,678	1,173
Loss on impairment	1,479	'	2,341	'
Reserve for uncollectible loan receivables and other receivables	9	27	298	77
Loss (gain) on sale of assets, net	2,445	'	2,458	374
Loss on extinguishment of debt	'	'	501	10,974
Total expenses	19,816	12,525	52,298	51,465
Net (loss) income	26,905	19,398	77,857	47,760
Net income	26,905	19,398	77,857	47,760
Aviv Healthcare Properties Limited Partnership | Non-Guarantor Subsidiaries	'	'	'	'
Revenues	'	'	'	'
Rental income	364	688	1,072	2,540
Total revenues	364	688	1,072	2,540
Expenses	'	'	'	'
Interest expense incurred	139	141	419	467
Depreciation and amortization	106	170	309	514
General and administrative	14	16	61	72
Transaction costs	'	'	1	15
Reserve for uncollectible loan receivables and other receivables	'	'	'	-10
Loss (gain) on sale of assets, net	'	13	'	-400
Total expenses	259	340	790	658
Net (loss) income	105	348	282	1,882
Net income	$105	$348	$282	$1,882

Condensed_Consolidating_Statem1

Condensed Consolidating Statement of Cash Flow (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash (used in) provided by operating activities	$70,088	$36,395
Investing activities	'	'
Purchase of real estate	-368,870	-38,076
Proceeds from sales of real estate, net	1,337	4,842
Capital improvements	-10,293	-9,909
Development projects	-30,316	-14,380
Loan receivables received from others	7,613	3,222
Loan receivables funded to others	-12,410	-2,707
Net cash provided by (used in) investing activities	-412,939	-57,008
Financing activities	'	'
Borrowings of debt	283,000	160,000
Repayment of debt	-128,117	-353,203
Payment of financing costs	-4,588	-5,290
Capital contributions	60	425
Cost of raising capital	-10,551	-25,380
Units issued for settlement of vested stock and exercised unit options, net	3,053	'
Cash distributions to partners	-12,449	-16,276
Net cash provided by (used in) financing activities	307,921	14,969
Net (decrease) increase in cash and cash equivalents	-34,930	-5,644
Cash and cash equivalents:	'	'
Beginning of period	50,764	17,876
End of period	15,834	12,232
Aviv Healthcare Properties Limited Partnership	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash (used in) provided by operating activities	70,088	36,395
Investing activities	'	'
Purchase of real estate	-368,870	-38,076
Proceeds from sales of real estate, net	1,337	4,842
Capital improvements	-10,293	-9,909
Development projects	-30,316	-14,380
Loan receivables received from others	7,613	3,222
Loan receivables funded to others	-12,410	-2,707
Net cash provided by (used in) investing activities	-412,939	-57,008
Financing activities	'	'
Borrowings of debt	283,000	160,000
Repayment of debt	-128,117	-353,203
Payment of financing costs	-4,588	-5,290
Capital contributions	60	425
Initial public offering proceeds	221,720	303,600
Cost of raising capital	-10,551	-25,380
Units issued for settlement of vested stock and exercised unit options, net	3,053	'
Cash distributions to partners	-56,646	-65,183
Net cash provided by (used in) financing activities	307,921	14,969
Net (decrease) increase in cash and cash equivalents	-34,930	-5,644
Cash and cash equivalents:	'	'
Beginning of period	50,764	17,876
End of period	15,834	12,232
Aviv Healthcare Properties Limited Partnership | Issuers	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash (used in) provided by operating activities	-358,512	-220,414
Investing activities	'	'
Capital improvements	'	-6
Loan receivables received from others	2,102	2,041
Loan receivables funded to others	-7,648	-370
Net cash provided by (used in) investing activities	-5,546	1,665
Financing activities	'	'
Borrowings of debt	185,000	'
Repayment of debt	-10,000	'
Payment of financing costs	-4,588	'
Capital contributions	60	425
Initial public offering proceeds	221,720	303,600
Cost of raising capital	-10,551	-25,380
Units issued for settlement of vested stock and exercised unit options, net	3,053	'
Cash distributions to partners	-56,656	-65,183
Net cash provided by (used in) financing activities	328,038	213,462
Net (decrease) increase in cash and cash equivalents	-36,020	-5,287
Cash and cash equivalents:	'	'
Beginning of period	50,709	16,869
End of period	14,689	11,582
Aviv Healthcare Properties Limited Partnership | Subsidiary Guarantors	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash (used in) provided by operating activities	428,124	259,381
Investing activities	'	'
Purchase of real estate	-368,870	-38,076
Proceeds from sales of real estate, net	1,337	1,772
Capital improvements	-9,673	-9,865
Development projects	-30,316	-14,380
Loan receivables received from others	5,511	1,181
Loan receivables funded to others	-4,762	-2,387
Net cash provided by (used in) investing activities	-406,773	-61,705
Financing activities	'	'
Borrowings of debt	98,000	160,000
Repayment of debt	-118,000	-353,091
Payment of financing costs	'	-5,290
Net cash provided by (used in) financing activities	-20,000	-198,381
Net (decrease) increase in cash and cash equivalents	1,351	-705
Cash and cash equivalents:	'	'
Beginning of period	-714	-1,861
End of period	637	-2,566
Aviv Healthcare Properties Limited Partnership | Non-Guarantor Subsidiaries	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash (used in) provided by operating activities	476	-2,572
Investing activities	'	'
Proceeds from sales of real estate, net	'	3,070
Capital improvements	-620	-38
Net cash provided by (used in) investing activities	-620	3,032
Financing activities	'	'
Repayment of debt	-117	-112
Net cash provided by (used in) financing activities	-117	-112
Net (decrease) increase in cash and cash equivalents	-261	348
Cash and cash equivalents:	'	'
Beginning of period	769	526
End of period	$508	$874